Raras
Buscar doenças, sintomas, genes...
Anemia aplásica rara

Anemia resultante de insuficiência da medula óssea (medula óssea aplásica ou hipoplásica). A produção de eritroblastos e glóbulos vermelhos está acentuadamente diminuída e também pode estar associada à diminuição da produção de granulócitos (granulocitopenia) e plaquetas (trombocitopenia). A anemia aplástica pode ser idiopática ou secundária devido a danos na medula óssea por toxinas, radiação ou fatores imunológicos.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Anemia resultante de insuficiência da medula óssea (medula óssea aplásica ou hipoplásica). A produção de eritroblastos e glóbulos vermelhos está acentuadamente diminuída e também pode estar associada à diminuição da produção de granulócitos (granulocitopenia) e plaquetas (trombocitopenia). A anemia aplástica pode ser idiopática ou secundária devido a danos na medula óssea por toxinas, radiação ou fatores imunológicos.

Medicamentos
13 registrados
RUXOLITINIB PHOSPHATE, FEDRATINIB HYDROCHLORIDE, PACRITINIB CITRATE

Tem tratamento?

13 medicamentos registrados
Ver detalhes, fases e interações →
RUXOLITINIB PHOSPHATEFEDRATINIB HYDROCHLORIDEPACRITINIB CITRATEECULIZUMABRAVULIZUMABPEGCETACOPLANMOMELOTINIBPEGINTERFERON ALFA-2APEGINTERFERON ALFA-2BFEDRATINIB
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
45 sintomas
🩸
Sangue
32 sintomas
😀
Face
31 sintomas
🫃
Digestivo
25 sintomas
🫘
Rins
24 sintomas
👁️
Olhos
22 sintomas

+ 178 sintomas em outras categorias

Características mais comuns

100%prev.
Anemia aplástica
Hipercelularidade da medula óssea
Refluxo vesicoureteral
Paralisia facial
Retardo do crescimento pós-natal
Primeiro metacarpo curto
445sintomas
Muito frequente (1)
Sem dados (444)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 445 características clínicas mais associadas, ordenadas por frequência.

Anemia aplásticaAplastic anemia
Muito frequente100%
Hipercelularidade da medula ósseaBone marrow hypercellularity
Refluxo vesicoureteralVesicoureteral reflux
Paralisia facialFacial palsy
Retardo do crescimento pós-natalPostnatal growth retardation

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa2
Últimos 10 anos200publicações
Pico2025129 papers
Linha do tempo
2024Hoje · 2026🧪 1994Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

64 genes identificados com associação a esta condição.

TET2Methylcytosine dioxygenase TET2Candidate gene tested inTolerante
FUNÇÃO

Dioxygenase that catalyzes the conversion of the modified genomic base 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC) and plays a key role in active DNA demethylation. Has a preference for 5-hydroxymethylcytosine in CpG motifs. Also mediates subsequent conversion of 5hmC into 5-formylcytosine (5fC), and conversion of 5fC to 5-carboxylcytosine (5caC). Conversion of 5mC into 5hmC, 5fC and 5caC probably constitutes the first step in cytosine demethylation. Methylation at the C5 position

LOCALIZAÇÃO

NucleusChromosome

VIAS BIOLÓGICAS (2)
TET1,2,3 and TDG demethylate DNASpecification of primordial germ cells
EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
12.3 TPM
Cervix Ectocervix
10.8 TPM
Vagina
10.4 TPM
Skin Not Sun Exposed Suprapubic
10.3 TPM
Skin Sun Exposed Lower leg
10.2 TPM
OUTRAS DOENÇAS (11)
myelodysplastic syndromeimmunodeficiency 75acute myeloid leukemia with multilineage dysplasiamyelodysplastic syndrome with ring sideroblasts
HGNC:25941UniProt:Q6N021
TERTTelomerase reverse transcriptaseMENDELIANRestrito
FUNÇÃO

Telomerase is a ribonucleoprotein enzyme essential for the replication of chromosome termini in most eukaryotes. Active in progenitor and cancer cells. Inactive, or very low activity, in normal somatic cells. Catalytic component of the teleromerase holoenzyme complex whose main activity is the elongation of telomeres by acting as a reverse transcriptase that adds simple sequence repeats to chromosome ends by copying a template sequence within the RNA component of the enzyme. Catalyzes the RNA-de

LOCALIZAÇÃO

Nucleus, nucleolusNucleus, nucleoplasmNucleusChromosome, telomereCytoplasmNucleus, PML body

VIAS BIOLÓGICAS (3)
Telomere Extension By TelomeraseFormation of the beta-catenin:TCF transactivating complexRegulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence
EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
2.7 TPM
Intestino delgado
0.7 TPM
Brain Caudate basal ganglia
0.6 TPM
Cólon transverso
0.5 TPM
Brain Nucleus accumbens basal ganglia
0.5 TPM
OUTRAS DOENÇAS (13)
dyskeratosis congenita, autosomal dominant 2pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1adrenal cortex carcinomaclear cell sarcoma of kidney
HGNC:11730UniProt:O14746
SBDSRibosome maturation protein SBDSPOLYGENICTolerante
FUNÇÃO

Required for the assembly of mature ribosomes and ribosome biogenesis. Together with EFL1, triggers the GTP-dependent release of EIF6 from 60S pre-ribosomes in the cytoplasm, thereby activating ribosomes for translation competence by allowing 80S ribosome assembly and facilitating EIF6 recycling to the nucleus, where it is required for 60S rRNA processing and nuclear export. Required for normal levels of protein synthesis. May play a role in cellular stress resistance. May play a role in cellula

LOCALIZAÇÃO

CytoplasmNucleus, nucleolusNucleus, nucleoplasmCytoplasm, cytoskeleton, spindle

MECANISMO DE DOENÇA

Shwachman-Diamond syndrome 1

A form of Shwachman-Diamond syndrome, a disorder characterized by hematopoietic abnormalities, exocrine pancreatic dysfunction, and skeletal dysplasia. Intermittent or chronic neutropenia is the most common hematological manifestation, followed by anemia and thrombocytopenia. Some patients progress to bone marrow failure, myelodysplastic syndrome and malignant transformation, with acute myelogenous leukemia being the most common. Exocrine pancreatic dysfunction is generally the first presenting symptom in infancy. Short stature and metaphyseal dysplasia are the most frequent skeletal manifestations. SDS1 inheritance is autosomal recessive.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
563.0 TPM
Aorta
423.0 TPM
Artéria coronária
381.9 TPM
Nervo tibial
305.7 TPM
Esôfago - Muscular
286.7 TPM
OUTRAS DOENÇAS (5)
Shwachman-Diamond syndrome 1SBDS-related severe neonatal spondylometaphyseal dysplasiaShwachman-Diamond syndromeidiopathic aplastic anemia
HGNC:19440UniProt:Q9Y3A5
RPL35Large ribosomal subunit protein uL29Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Component of the large ribosomal subunit (PubMed:12962325, PubMed:23636399, PubMed:32669547). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:12962325, PubMed:23636399, PubMed:32669547)

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (10)
Formation of a pool of free 40S subunitsRibosome Quality Control (RQC) complex extracts and degrades nascent peptideMajor pathway of rRNA processing in the nucleolus and cytosolGTP hydrolysis and joining of the 60S ribosomal subunitL13a-mediated translational silencing of Ceruloplasmin expression
MECANISMO DE DOENÇA

Diamond-Blackfan anemia 19

A form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies. DBA19 inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
2429.0 TPM
Ovário
2365.1 TPM
Skin Not Sun Exposed Suprapubic
1898.6 TPM
Skin Sun Exposed Lower leg
1815.1 TPM
Cervix Ectocervix
1813.0 TPM
OUTRAS DOENÇAS (2)
Diamond-Blackfan anemia 19Diamond-Blackfan anemia
HGNC:10344UniProt:P42766
ERCC6L2DNA excision repair protein ERCC-6-like 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Promotes double-strand break (DSB) end-joining and facilitates programmed recombination by controlling how DNA ends are joined in a spatially oriented manner during repair (By similarity). Also plays a role in DNA repair by restricting DNA end resection in double strand break (DSB) repair (PubMed:24507776, PubMed:37014751). Facilitates replication of complex DNA regions and regulates the maintenance of chromatin structure (PubMed:37014751)

LOCALIZAÇÃO

NucleusCytoplasm, cytoskeleton, microtubule organizing center, centrosomeMitochondrionChromosome, centromere

MECANISMO DE DOENÇA

Bone marrow failure syndrome 2

An autosomal recessive disorder characterized by trilineage bone marrow failure, bone marrow hypocellularity, learning difficulties, and microcephaly. Insufficient hematopoiesis results in peripheral blood cytopenias, affecting myeloid, erythroid and megakaryocyte lines. Cutaneous features and increased chromosome breakage are not features.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
8.8 TPM
Cervix Ectocervix
7.6 TPM
Cervix Endocervix
7.4 TPM
Ovário
7.2 TPM
Útero
6.6 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
pancytopenia-developmental delay syndromeinherited acute myeloid leukemia
HGNC:26922UniProt:Q5T890
RPS20Small ribosomal subunit protein uS10Candidate gene tested inAltamente restrito
FUNÇÃO

Component of the small ribosomal subunit (PubMed:23636399). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399)

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (10)
Formation of a pool of free 40S subunitsMajor pathway of rRNA processing in the nucleolus and cytosolSARS-CoV-2 modulates host translation machinerySARS-CoV-1 modulates host translation machineryViral mRNA Translation
EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
1353.5 TPM
Linfócitos
957.4 TPM
Cervix Ectocervix
885.0 TPM
Cervix Endocervix
834.7 TPM
Tecido adiposo
749.1 TPM
OUTRAS DOENÇAS (2)
familial colorectal cancer type XDiamond-Blackfan anemia
HGNC:10405UniProt:P60866
BRCA1Breast cancer type 1 susceptibility proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage (PubMed:10500182, PubMed:12887909, PubMed:12890688, PubMed:14976165, PubMed:16818604, PubMed:17525340, PubMed:19261748). It is unclear whether it also mediates the formation of other types of polyubiquitin chains (PubMed:12890688). The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular path

LOCALIZAÇÃO

NucleusChromosomeCytoplasm

VIAS BIOLÓGICAS (10)
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaksMetalloprotease DUBsTP53 Regulates Transcription of DNA Repair GenesTranscriptional Regulation by E2F6Meiotic synapsis
MECANISMO DE DOENÇA

Breast cancer

A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case.

OUTRAS DOENÇAS (12)
Fanconi anemia, complementation group Sbreast-ovarian cancer, familial, susceptibility to, 1BRCA1-related cancer predispositionprostate cancer, hereditary
HGNC:1100UniProt:P38398
RFWD3E3 ubiquitin-protein ligase RFWD3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

E3 ubiquitin-protein ligase required for the repair of DNA interstrand cross-links (ICL) in response to DNA damage (PubMed:21504906, PubMed:21558276, PubMed:26474068, PubMed:28575657, PubMed:28575658, PubMed:33321094). Plays a key role in RPA-mediated DNA damage signaling and repair (PubMed:21504906, PubMed:21558276, PubMed:26474068, PubMed:28575657, PubMed:28575658, PubMed:28691929). Acts by mediating ubiquitination of the RPA complex (RPA1, RPA2 and RPA3 subunits) and RAD51 at stalled replicat

LOCALIZAÇÃO

NucleusNucleus, PML bodyCytoplasm

MECANISMO DE DOENÇA

Fanconi anemia, complementation group W

A form of Fanconi anemia, a disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
41.9 TPM
Testículo
37.6 TPM
Fibroblastos
18.6 TPM
Skin Sun Exposed Lower leg
15.7 TPM
Skin Not Sun Exposed Suprapubic
14.7 TPM
OUTRAS DOENÇAS (2)
Fanconi anemia, complementation group WFanconi anemia
HGNC:25539UniProt:Q6PCD5
MPLThrombopoietin receptorDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Receptor for thrombopoietin that regulates hematopoietic stem cell renewal, megakaryocyte differentiation, and platelet formation. Upon activation by THPO, induces rapid tyrosine phosphorylation and activation of JAK2, providing docking sites for many signaling proteins such as STAT5, SHIP/INPP5D, GRB2, SOS1 and PI3K (PubMed:15899890, PubMed:37633268). In turn, These signaling cascades lead to the proliferation, survival, and differentiation of megakaryocytes, ultimately leading to increased pla

LOCALIZAÇÃO

Cell membraneGolgi apparatusCell surface

VIAS BIOLÓGICAS (1)
Platelet Aggregation (Plug Formation)
MECANISMO DE DOENÇA

Amegakaryocytic thrombocytopenia, congenital, 1

An autosomal recessive form of congenital amegakaryocytic thrombocytopenia, a hematologic disorder characterized by severe reduction of megakaryocytes and platelets at birth, and evolving into generalized bone marrow aplasia during childhood.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
1.5 TPM
Ovário
0.7 TPM
Pulmão
0.7 TPM
Nervo tibial
0.6 TPM
Tecido adiposo
0.5 TPM
OUTRAS DOENÇAS (6)
thrombocythemia 2primary myelofibrosiscongenital amegakaryocytic thrombocytopenia 1essential thrombocythemia
HGNC:7217UniProt:P40238
MAD2L2Mitotic spindle assembly checkpoint protein MAD2BDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Adapter protein able to interact with different proteins and involved in different biological processes (PubMed:11459825, PubMed:11459826, PubMed:17296730, PubMed:17719540, PubMed:19443654, PubMed:29656893). Mediates the interaction between the error-prone DNA polymerase zeta catalytic subunit REV3L and the inserter polymerase REV1, thereby mediating the second polymerase switching in translesion DNA synthesis (PubMed:20164194, PubMed:23143872). Translesion DNA synthesis releases the replication

LOCALIZAÇÃO

NucleusCytoplasm, cytoskeleton, spindleCytoplasmChromosome

VIAS BIOLÓGICAS (3)
Translesion synthesis by POLKTranslesion synthesis by REV1Translesion synthesis by POLI
MECANISMO DE DOENÇA

Fanconi anemia, complementation group V

A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
68.8 TPM
Linfócitos
35.5 TPM
Fibroblastos
34.8 TPM
Nervo tibial
29.1 TPM
Cérebro - Hemisfério cerebelar
28.0 TPM
OUTRAS DOENÇAS (2)
Fanconi anemia complementation group VFanconi anemia
HGNC:6764UniProt:Q9UI95
XRCC2DNA repair protein XRCC2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in the homologous recombination repair (HRR) pathway of double-stranded DNA, thought to repair chromosomal fragmentation, translocations and deletions. Part of the RAD51 paralog protein complex BCDX2 which acts in the BRCA1-BRCA2-dependent HR pathway. Upon DNA damage, BCDX2 acts downstream of BRCA2 recruitment and upstream of RAD51 recruitment. BCDX2 binds predominantly to the intersection of the four duplex arms of the Holliday junction and to junction of replication forks. The BCDX2 c

LOCALIZAÇÃO

NucleusCytoplasm, cytoskeleton, microtubule organizing center, centrosome

VIAS BIOLÓGICAS (9)
Resolution of D-loop Structures through Holliday Junction IntermediatesHDR through Homologous Recombination (HRR)Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)Homologous DNA Pairing and Strand ExchangePresynaptic phase of homologous DNA pairing and strand exchange
MECANISMO DE DOENÇA

Fanconi anemia, complementation group U

A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair.

EXPRESSÃO TECIDUAL(Tecido-específico)
Linfócitos
13.0 TPM
Testículo
6.4 TPM
Fibroblastos
3.1 TPM
Esôfago - Mucosa
1.5 TPM
Intestino delgado
1.0 TPM
OUTRAS DOENÇAS (6)
premature ovarian failure 17Fanconi anemia complementation group Uspermatogenic failure 50hereditary breast carcinoma
HGNC:12829UniProt:O43543
RPS29Small ribosomal subunit protein uS14Disease-causing germline mutation(s) inDesconhecido
FUNÇÃO

Component of the small ribosomal subunit (PubMed:23636399, PubMed:25901680, PubMed:25957688). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399, PubMed:25901680, PubMed:25957688)

LOCALIZAÇÃO

Cytoplasm, cytosolCytoplasmRough endoplasmic reticulum

VIAS BIOLÓGICAS (10)
Formation of a pool of free 40S subunitsMajor pathway of rRNA processing in the nucleolus and cytosolSARS-CoV-2 modulates host translation machinerySARS-CoV-1 modulates host translation machineryViral mRNA Translation
MECANISMO DE DOENÇA

Diamond-Blackfan anemia 13

An autosomal dominant form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
176.7 TPM
Ovário
147.4 TPM
Fibroblastos
114.4 TPM
Skin Sun Exposed Lower leg
107.2 TPM
Cervix Ectocervix
104.8 TPM
OUTRAS DOENÇAS (2)
Diamond-Blackfan anemia 13Diamond-Blackfan anemia
HGNC:10419UniProt:P62273
BRIP1Fanconi anemia group J proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

DNA-dependent ATPase and 5'-3' DNA helicase required for the maintenance of chromosomal stability (PubMed:11301010, PubMed:14983014, PubMed:16116421, PubMed:16153896, PubMed:17596542, PubMed:36608669). Acts late in the Fanconi anemia pathway, after FANCD2 ubiquitination (PubMed:14983014, PubMed:16153896). Involved in the repair of DNA double-strand breaks by homologous recombination in a manner that depends on its association with BRCA1 (PubMed:14983014, PubMed:16153896). Involved in the repair

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (1)
Cytosolic iron-sulfur cluster assembly
MECANISMO DE DOENÇA

Breast cancer

A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case.

OUTRAS DOENÇAS (4)
Fanconi anemia complementation group JFanconi anemiahereditary breast ovarian cancer syndromehereditary breast carcinoma
HGNC:20473UniProt:Q9BX63
RPL26Large ribosomal subunit protein uL24Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Component of the large ribosomal subunit (PubMed:23636399, PubMed:26100019, PubMed:32669547). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399, PubMed:26100019, PubMed:32669547)

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (10)
Formation of a pool of free 40S subunitsRibosome Quality Control (RQC) complex extracts and degrades nascent peptideMajor pathway of rRNA processing in the nucleolus and cytosolGTP hydrolysis and joining of the 60S ribosomal subunitL13a-mediated translational silencing of Ceruloplasmin expression
MECANISMO DE DOENÇA

Diamond-Blackfan anemia 11

An autosomal dominant form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
1462.9 TPM
Ovário
1410.2 TPM
Fibroblastos
997.2 TPM
Cervix Ectocervix
905.0 TPM
Cervix Endocervix
899.9 TPM
OUTRAS DOENÇAS (2)
Diamond-Blackfan anemia 11Diamond-Blackfan anemia
HGNC:10327UniProt:P61254
NBNNibrinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the MRN complex, which plays a central role in double-strand break (DSB) repair, DNA recombination, maintenance of telomere integrity and meiosis (PubMed:10888888, PubMed:15616588, PubMed:18411307, PubMed:18583988, PubMed:18678890, PubMed:19759395, PubMed:23115235, PubMed:28216226, PubMed:28867292, PubMed:9705271). The MRN complex is involved in the repair of DNA double-strand breaks (DSBs) via homologous recombination (HR), an error-free mechanism which primarily occurs during S an

LOCALIZAÇÃO

NucleusChromosomeNucleus, PML bodyChromosome, telomere

VIAS BIOLÓGICAS (1)
Sensing of DNA Double Strand Breaks
MECANISMO DE DOENÇA

Nijmegen breakage syndrome

A disorder characterized by chromosomal instability, radiation sensitivity, microcephaly, growth retardation, immunodeficiency and predisposition to cancer, particularly to lymphoid malignancies.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
67.2 TPM
Esôfago - Muscular
38.3 TPM
Nervo tibial
37.1 TPM
Esôfago - Junção
36.3 TPM
Fibroblastos
35.1 TPM
OUTRAS DOENÇAS (5)
Nijmegen breakage syndromeaplastic anemialeukemia, acute lymphocytic, susceptibility to, 1prostate cancer, hereditary
HGNC:7652UniProt:O60934
RAD51CDNA repair protein RAD51 homolog 3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Essential for the homologous recombination (HR) pathway of DNA repair. Involved in the homologous recombination repair (HRR) pathway of double-stranded DNA breaks arising during DNA replication or induced by DNA-damaging agents. Part of the RAD51 paralog protein complexes BCDX2 and CX3 which act at different stages of the BRCA1-BRCA2-dependent HR pathway. Upon DNA damage, BCDX2 seems to act downstream of BRCA2 recruitment and upstream of RAD51 recruitment; CX3 seems to act downstream of RAD51 re

LOCALIZAÇÃO

NucleusCytoplasmCytoplasm, perinuclear regionMitochondrion

VIAS BIOLÓGICAS (10)
Resolution of D-loop Structures through Holliday Junction IntermediatesHDR through Homologous Recombination (HRR)Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)Homologous DNA Pairing and Strand ExchangePresynaptic phase of homologous DNA pairing and strand exchange
MECANISMO DE DOENÇA

Fanconi anemia complementation group O

A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
13.8 TPM
Linfócitos
11.8 TPM
Cérebro - Hemisfério cerebelar
8.9 TPM
Brain Frontal Cortex BA9
8.0 TPM
Artéria tibial
7.3 TPM
OUTRAS DOENÇAS (4)
Fanconi anemia complementation group Ohereditary breast ovarian cancer syndromeFanconi anemiabreast-ovarian cancer, familial, susceptibility to, 3
HGNC:9820UniProt:O43502
FANCFFanconi anemia group F proteinDisease-causing germline mutation(s) inDesconhecido
FUNÇÃO

DNA repair protein that may operate in a postreplication repair or a cell cycle checkpoint function. May be implicated in interstrand DNA cross-link repair and in the maintenance of normal chromosome stability (By similarity)

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
PKR-mediated signaling
MECANISMO DE DOENÇA

Fanconi anemia complementation group F

A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
13.4 TPM
Testículo
12.7 TPM
Baço
8.8 TPM
Pituitária
8.5 TPM
Cervix Endocervix
7.5 TPM
OUTRAS DOENÇAS (2)
Fanconi anemia complementation group FFanconi anemia
HGNC:3587UniProt:Q9NPI8
ADA2Adenosine deaminase 2Candidate gene tested inTolerante
FUNÇÃO

Adenosine deaminase that may contribute to the degradation of extracellular adenosine, a signaling molecule that controls a variety of cellular responses. Requires elevated adenosine levels for optimal enzyme activity. Binds to cell surfaces via proteoglycans and may play a role in the regulation of cell proliferation and differentiation, independently of its enzyme activity

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (2)
Neutrophil degranulationSurfactant metabolism
MECANISMO DE DOENÇA

Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome

An autosomal recessive, systemic necrotizing vasculitis that affects medium and small arteries. The ensuing tissue ischemia can affect any organ, including the skin, musculoskeletal system, kidneys, gastrointestinal tract, and the cardiovascular and nervous systems. Organ involvement and disease severity are highly variable. Clinical features include recurrent ischemic stroke affecting the small vessels of the brain and resulting in neurologic dysfunction, recurrent fever, myalgias, livedoid rash, gastrointestinal pain and hepatosplenomegaly.

OUTRAS DOENÇAS (3)
vasculitis due to ADA2 deficiencySneddon syndromeDiamond-Blackfan anemia
HGNC:1839UniProt:Q9NZK5
RPL18Large ribosomal subunit protein eL18Candidate gene tested inAltamente restrito
FUNÇÃO

Component of the large ribosomal subunit (PubMed:12962325, PubMed:23636399, PubMed:25901680, PubMed:25957688, PubMed:32669547). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:12962325, PubMed:23636399, PubMed:25901680, PubMed:25957688, PubMed:32669547)

LOCALIZAÇÃO

Cytoplasm, cytosolCytoplasmRough endoplasmic reticulum

VIAS BIOLÓGICAS (10)
Formation of a pool of free 40S subunitsRibosome Quality Control (RQC) complex extracts and degrades nascent peptideMajor pathway of rRNA processing in the nucleolus and cytosolGTP hydrolysis and joining of the 60S ribosomal subunitL13a-mediated translational silencing of Ceruloplasmin expression
MECANISMO DE DOENÇA

Diamond-Blackfan anemia 18

A form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies. DBA18 inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
2269.1 TPM
Linfócitos
1309.3 TPM
Skin Sun Exposed Lower leg
1257.9 TPM
Skin Not Sun Exposed Suprapubic
1250.3 TPM
Cervix Ectocervix
1238.0 TPM
OUTRAS DOENÇAS (2)
Diamond-Blackfan anemia 18Diamond-Blackfan anemia
HGNC:10310UniProt:Q07020
ERCC4DNA repair endonuclease XPFDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalytic component of a structure-specific DNA repair endonuclease responsible for the 5-prime incision during DNA repair, and which is essential for nucleotide excision repair (NER) and interstrand cross-link (ICL) repair

LOCALIZAÇÃO

NucleusChromosome

VIAS BIOLÓGICAS (5)
HDR through Single Strand Annealing (SSA)Dual incision in TC-NERDual Incision in GG-NERFormation of Incision Complex in GG-NERFanconi Anemia Pathway
MECANISMO DE DOENÇA

Xeroderma pigmentosum complementation group F

An autosomal recessive pigmentary skin disorder characterized by solar hypersensitivity of the skin, high predisposition for developing cancers on areas exposed to sunlight and, in some cases, neurological abnormalities. The skin develops marked freckling and other pigmentation abnormalities. XP-F patients show a mild phenotype.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
13.8 TPM
Fibroblastos
6.2 TPM
Linfócitos
5.4 TPM
Cervix Endocervix
5.1 TPM
Fallopian Tube
5.1 TPM
OUTRAS DOENÇAS (7)
Fanconi anemia complementation group Qxeroderma pigmentosum group FXFE progeroid syndromexeroderma pigmentosum
HGNC:3436UniProt:Q92889
RPS27Small ribosomal subunit protein eS27Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Component of the small ribosomal subunit (PubMed:23636399, PubMed:8706699). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399). Required for proper rRNA processing and maturation of 18S rRNAs (PubMed:25424902). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and

LOCALIZAÇÃO

CytoplasmNucleus, nucleolus

VIAS BIOLÓGICAS (10)
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signalRHO GTPases Activate ForminsMitotic PrometaphaseEML4 and NUDC in mitotic spindle formationResolution of Sister Chromatid Cohesion
MECANISMO DE DOENÇA

Diamond-Blackfan anemia 17

An autosomal dominant form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
4528.6 TPM
Cervix Endocervix
2936.8 TPM
Linfócitos
2822.3 TPM
Cervix Ectocervix
2812.5 TPM
Fallopian Tube
2427.5 TPM
OUTRAS DOENÇAS (2)
Diamond-Blackfan anemia 17Diamond-Blackfan anemia
HGNC:10416UniProt:P42677
FANCD2Fanconi anemia group D2 proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for maintenance of chromosomal stability (PubMed:11239453, PubMed:14517836). Promotes accurate and efficient pairing of homologs during meiosis (PubMed:14517836). Involved in the repair of DNA double-strand breaks, both by homologous recombination and single-strand annealing (PubMed:15671039, PubMed:15650050, PubMed:30335751, PubMed:36385258). The FANCI-FANCD2 complex binds and scans double-stranded DNA (dsDNA) for DNA damage; this complex stalls at DNA junctions between double-stranded

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (2)
TP53 Regulates Transcription of DNA Repair GenesFanconi Anemia Pathway
MECANISMO DE DOENÇA

Fanconi anemia complementation group D2

A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
29.3 TPM
Testículo
22.2 TPM
Baço
7.5 TPM
Intestino delgado
4.5 TPM
Fibroblastos
4.1 TPM
OUTRAS DOENÇAS (2)
Fanconi anemia complementation group D2Fanconi anemia
HGNC:3585UniProt:Q9BXW9
RPL15Large ribosomal subunit protein eL15Disease-causing germline mutation(s) inDesconhecido
FUNÇÃO

Component of the large ribosomal subunit. The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (10)
Formation of a pool of free 40S subunitsRibosome Quality Control (RQC) complex extracts and degrades nascent peptideMajor pathway of rRNA processing in the nucleolus and cytosolGTP hydrolysis and joining of the 60S ribosomal subunitL13a-mediated translational silencing of Ceruloplasmin expression
MECANISMO DE DOENÇA

Diamond-Blackfan anemia 12

An autosomal dominant form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
907.0 TPM
Cervix Endocervix
635.4 TPM
Linfócitos
622.4 TPM
Cervix Ectocervix
616.6 TPM
Útero
582.7 TPM
OUTRAS DOENÇAS (2)
Diamond-Blackfan anemia 12Diamond-Blackfan anemia
HGNC:10306UniProt:P61313
PIGTGPI-anchor transamidase component PIGTDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the glycosylphosphatidylinositol-anchor (GPI-anchor) transamidase (GPI-T) complex that catalyzes the formation of the linkage between a proprotein and a GPI-anchor and participates in GPI anchored protein biosynthesis (PubMed:11483512, PubMed:12582175, PubMed:28327575, PubMed:34576938, PubMed:35165458, PubMed:35551457, PubMed:36970549, PubMed:37684232). May play a crucial role in GPI-T complex assembly in the luminal layer (PubMed:35165458, PubMed:35551457). Binds GPI-anchor (PubMed

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
Attachment of GPI anchor to uPAR
MECANISMO DE DOENÇA

Multiple congenital anomalies-hypotonia-seizures syndrome 3

An autosomal recessive syndrome characterized by distinct facial features, intellectual disability, hypotonia and seizures, in combination with abnormal skeletal, endocrine, and ophthalmologic findings including impaired vision, as well as abnormal motility of the eyes.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
53.6 TPM
Artéria coronária
42.9 TPM
Artéria tibial
38.8 TPM
Útero
35.9 TPM
Fibroblastos
35.5 TPM
OUTRAS DOENÇAS (2)
multiple congenital anomalies-hypotonia-seizures syndrome 3paroxysmal nocturnal hemoglobinuria 2
HGNC:14938UniProt:Q969N2
HEATR3HEAT repeat-containing protein 3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a role in ribosome biogenesis and in nuclear import of the 60S ribosomal protein L5/large ribosomal subunit protein uL18 (RPL5) (PubMed:35213692). Required for proper erythrocyte maturation (PubMed:35213692)

LOCALIZAÇÃO

MECANISMO DE DOENÇA

Diamond-Blackfan anemia 21

An autosomal recessive form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies. DBA21 patients manifest bone marrow failure, short stature, facial and acromelic dysmorphic features, and intellectual disability.

EXPRESSÃO TECIDUAL(Ubíquo)
Baço
23.9 TPM
Cérebro - Hemisfério cerebelar
23.3 TPM
Cerebelo
20.2 TPM
Fibroblastos
18.8 TPM
Linfócitos
16.9 TPM
INTERAÇÕES PROTEICAS (5)
OUTRAS DOENÇAS (2)
Diamond-Blackfan anemia 21Diamond-Blackfan anemia
HGNC:26087UniProt:Q7Z4Q2
RPS26Small ribosomal subunit protein eS26Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Component of the small ribosomal subunit (PubMed:23636399, PubMed:25901680, PubMed:25957688). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399, PubMed:25901680, PubMed:25957688)

LOCALIZAÇÃO

Cytoplasm, cytosolCytoplasmRough endoplasmic reticulum

VIAS BIOLÓGICAS (10)
Formation of a pool of free 40S subunitsMajor pathway of rRNA processing in the nucleolus and cytosolSARS-CoV-2 modulates host translation machinerySARS-CoV-1 modulates host translation machineryViral mRNA Translation
MECANISMO DE DOENÇA

Diamond-Blackfan anemia 10

An autosomal dominant form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
688.3 TPM
Ovário
658.3 TPM
Cervix Endocervix
524.3 TPM
Fibroblastos
495.1 TPM
Glândula adrenal
446.2 TPM
OUTRAS DOENÇAS (2)
Diamond-Blackfan anemia 10Diamond-Blackfan anemia
HGNC:10414UniProt:P62854
RAD51DNA repair protein RAD51 homolog 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Plays an important role in homologous strand exchange, a key step in DNA repair through homologous recombination (HR) (PubMed:12205100, PubMed:18417535, PubMed:20231364, PubMed:20348101, PubMed:22325354, PubMed:23509288, PubMed:23754376, PubMed:26681308, PubMed:28575658, PubMed:32640219). Binds to single-stranded DNA in an ATP-dependent manner to form nucleoprotein filaments which are essential for the homology search and strand exchange (PubMed:12205100, PubMed:18417535, PubMed:15226506, PubMed

LOCALIZAÇÃO

NucleusCytoplasmCytoplasm, perinuclear regionMitochondrion matrixChromosomeCytoplasm, cytoskeleton, microtubule organizing center, centrosome

VIAS BIOLÓGICAS (4)
Presynaptic phase of homologous DNA pairing and strand exchangeHDR through Single Strand Annealing (SSA)Transcriptional Regulation by E2F6Meiotic recombination
MECANISMO DE DOENÇA

Breast cancer

A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case.

EXPRESSÃO TECIDUAL(Tecido-específico)
Linfócitos
26.5 TPM
Testículo
24.1 TPM
Fibroblastos
6.8 TPM
Esôfago - Mucosa
4.0 TPM
Cólon transverso
2.3 TPM
OUTRAS DOENÇAS (6)
Fanconi anemia complementation group Rmirror movements 2familial congenital mirror movementshereditary breast ovarian cancer syndrome
HGNC:9817UniProt:Q06609
BRCA2Breast cancer type 2 susceptibility proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in double-strand break repair and/or homologous recombination. Binds RAD51 and potentiates recombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA). Acts by targeting RAD51 to ssDNA over double-stranded DNA, enabling RAD51 to displace replication protein-A (RPA) from ssDNA and stabilizing RAD51-ssDNA filaments by blocking ATP hydrolysis. Part of a PALB2-scaffolded HR complex containing RAD51C and which is thought to play a role in DNA repair by HR. May

LOCALIZAÇÃO

NucleusCytoplasm, cytoskeleton, microtubule organizing center, centrosome

VIAS BIOLÓGICAS (3)
Presynaptic phase of homologous DNA pairing and strand exchangeHDR through MMEJ (alt-NHEJ)Meiotic recombination
MECANISMO DE DOENÇA

Breast cancer

A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case.

OUTRAS DOENÇAS (17)
Wilms tumor 1Fanconi anemia complementation group D1breast-ovarian cancer, familial, susceptibility to, 2BRCA2-related cancer predisposition
HGNC:1101UniProt:P51587
RPS7Small ribosomal subunit protein eS7Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Component of the small ribosomal subunit (PubMed:23636399). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399). Required for rRNA maturation (PubMed:19061985). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-r

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasmNucleus, nucleolus

VIAS BIOLÓGICAS (10)
Formation of a pool of free 40S subunitsMajor pathway of rRNA processing in the nucleolus and cytosolSARS-CoV-2 modulates host translation machinerySARS-CoV-1 modulates host translation machineryViral mRNA Translation
MECANISMO DE DOENÇA

Diamond-Blackfan anemia 8

An autosomal dominant form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
2452.2 TPM
Linfócitos
2265.7 TPM
Fibroblastos
1584.8 TPM
Skin Not Sun Exposed Suprapubic
1292.2 TPM
Cervix Ectocervix
1262.9 TPM
OUTRAS DOENÇAS (2)
Diamond-Blackfan anemia 8Diamond-Blackfan anemia
HGNC:10440UniProt:P62081
SH2B3SH2B adapter protein 3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Links T-cell receptor activation signal to phospholipase C-gamma-1, GRB2 and phosphatidylinositol 3-kinase

LOCALIZAÇÃO

VIAS BIOLÓGICAS (3)
Regulation of KIT signalingNegative regulation of FLT3Factors involved in megakaryocyte development and platelet production
MECANISMO DE DOENÇA

Celiac disease 13

A multifactorial, chronic disorder of the small intestine caused by intolerance to gluten. It is characterized by immune-mediated enteropathy associated with failed intestinal absorption, and malnutrition. In predisposed individuals, the ingestion of gluten-containing food such as wheat and rye induces a flat jejunal mucosa with infiltration of lymphocytes.

EXPRESSÃO TECIDUAL(Ubíquo)
Baço
56.0 TPM
Linfócitos
43.0 TPM
Pulmão
41.6 TPM
Fibroblastos
37.9 TPM
Adipose Visceral Omentum
34.1 TPM
OUTRAS DOENÇAS (5)
primary myelofibrosisthrombocythemia 1primary familial polycythemia due to EPO receptor mutationgrowth retardation-mild developmental delay-chronic hepatitis syndrome
HGNC:29605UniProt:Q9UQQ2
UBE2TUbiquitin-conjugating enzyme E2 TDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. Catalyzes monoubiquitination. Involved in mitomycin-C (MMC)-induced DNA repair. Acts as a specific E2 ubiquitin-conjugating enzyme for the Fanconi anemia complex by associating with E3 ubiquitin-protein ligase FANCL and catalyzing monoubiquitination of FANCD2, a key step in the DNA damage pathway (PubMed:16916645, PubMed:17938197, PubMed:19111657, PubMed:19589784, PubMed:28437106). Also mediates monoub

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (2)
Fanconi Anemia PathwaySynthesis of active ubiquitin: roles of E1 and E2 enzymes
MECANISMO DE DOENÇA

Fanconi anemia complementation group T

A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
92.9 TPM
Testículo
42.7 TPM
Fibroblastos
29.0 TPM
Brain Frontal Cortex BA9
18.6 TPM
Brain Nucleus accumbens basal ganglia
13.8 TPM
OUTRAS DOENÇAS (2)
Fanconi anemia complementation group TFanconi anemia
HGNC:25009UniProt:Q9NPD8
RPS24Small ribosomal subunit protein eS24Disease-causing germline mutation(s) inDesconhecido
FUNÇÃO

Component of the small ribosomal subunit (PubMed:23636399). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399). Required for processing of pre-rRNA and maturation of 40S ribosomal subunits (PubMed:18230666). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and rib

LOCALIZAÇÃO

CytoplasmNucleus, nucleolus

VIAS BIOLÓGICAS (10)
Formation of a pool of free 40S subunitsMajor pathway of rRNA processing in the nucleolus and cytosolSARS-CoV-2 modulates host translation machinerySARS-CoV-1 modulates host translation machineryViral mRNA Translation
MECANISMO DE DOENÇA

Diamond-Blackfan anemia 3

An autosomal dominant form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of developing leukemia. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
1214.1 TPM
Linfócitos
881.7 TPM
Cervix Endocervix
794.4 TPM
Cervix Ectocervix
793.9 TPM
Fibroblastos
734.1 TPM
OUTRAS DOENÇAS (2)
Diamond-Blackfan anemia 3Diamond-Blackfan anemia
HGNC:10411UniProt:P62847
PIGAPhosphatidylinositol N-acetylglucosaminyltransferase subunit ADisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Catalytic subunit of the glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex that catalyzes the transfer of N-acetylglucosamine from UDP-N-acetylglucosamine to phosphatidylinositol and participates in the first step of GPI biosynthesis

LOCALIZAÇÃO

Rough endoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
Synthesis of glycosylphosphatidylinositol (GPI)
MECANISMO DE DOENÇA

Paroxysmal nocturnal hemoglobinuria 1

A disorder characterized by hemolytic anemia with hemoglobinuria, thromboses in large vessels, and a deficiency in hematopoiesis. Red blood cell breakdown with release of hemoglobin into the urine is manifested most prominently by dark-colored urine in the morning.

EXPRESSÃO TECIDUAL(Ubíquo)
Pulmão
15.2 TPM
Skin Not Sun Exposed Suprapubic
11.5 TPM
Linfócitos
10.6 TPM
Tireoide
9.4 TPM
Skin Sun Exposed Lower leg
8.8 TPM
OUTRAS DOENÇAS (5)
ferro-cerebro-cutaneous syndromeparoxysmal nocturnal hemoglobinuria 1multiple congenital anomalies-hypotonia-seizures syndrome 2paroxysmal nocturnal hemoglobinuria
HGNC:8957UniProt:P37287
RPL5Large ribosomal subunit protein uL18Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Component of the ribosome, a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell. The small ribosomal subunit (SSU) binds messenger RNAs (mRNAs) and translates the encoded message by selecting cognate aminoacyl-transfer RNA (tRNA) molecules. The large subunit (LSU) contains the ribosomal catalytic site termed the peptidyl transferase center (PTC), which catalyzes the formation of peptide bonds, thereby polymerizing the amino acids delivered by tRNAs into a polyp

LOCALIZAÇÃO

CytoplasmNucleus, nucleolus

VIAS BIOLÓGICAS (10)
Formation of a pool of free 40S subunitsRibosome Quality Control (RQC) complex extracts and degrades nascent peptideMajor pathway of rRNA processing in the nucleolus and cytosolGTP hydrolysis and joining of the 60S ribosomal subunitL13a-mediated translational silencing of Ceruloplasmin expression
MECANISMO DE DOENÇA

Diamond-Blackfan anemia 6

An autosomal dominant form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
4772.8 TPM
Linfócitos
2937.8 TPM
Cervix Ectocervix
2573.5 TPM
Cervix Endocervix
2553.4 TPM
Útero
2508.4 TPM
OUTRAS DOENÇAS (2)
Diamond-Blackfan anemia 6Diamond-Blackfan anemia
HGNC:10360UniProt:P46777
TSR2Pre-rRNA-processing protein TSR2 homologDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

May be involved in 20S pre-rRNA processing

LOCALIZAÇÃO

MECANISMO DE DOENÇA

Diamond-Blackfan anemia 14, with mandibulofacial dysostosis

An X-linked recessive form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
201.1 TPM
Brain Frontal Cortex BA9
166.3 TPM
Brain Nucleus accumbens basal ganglia
142.2 TPM
Hipotálamo
141.8 TPM
Substância negra
140.9 TPM
OUTRAS DOENÇAS (2)
Diamond-Blackfan anemia 14 with mandibulofacial dysostosisDiamond-Blackfan anemia
HGNC:25455UniProt:Q969E8
FANCLE3 ubiquitin-protein ligase FANCLDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Ubiquitin ligase protein that mediates monoubiquitination of FANCD2 in the presence of UBE2T, a key step in the DNA damage pathway (PubMed:12973351, PubMed:16916645, PubMed:17938197, PubMed:19111657, PubMed:24389026). Also mediates monoubiquitination of FANCI (PubMed:19589784). May stimulate the ubiquitin release from UBE2W. May be required for proper primordial germ cell proliferation in the embryonic stage, whereas it is probably not needed for spermatogonial proliferation after birth

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (1)
PKR-mediated signaling
MECANISMO DE DOENÇA

Fanconi anemia complementation group L

A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
51.5 TPM
Linfócitos
44.1 TPM
Glândula adrenal
32.0 TPM
Testículo
28.2 TPM
Útero
27.3 TPM
OUTRAS DOENÇAS (2)
Fanconi anemia complementation group LFanconi anemia
HGNC:20748UniProt:Q9NW38
RPS10Small ribosomal subunit protein eS10Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Component of the 40S ribosomal subunit (PubMed:23636399). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399)

LOCALIZAÇÃO

CytoplasmNucleus, nucleolus

VIAS BIOLÓGICAS (10)
Formation of a pool of free 40S subunitsMajor pathway of rRNA processing in the nucleolus and cytosolSARS-CoV-2 modulates host translation machinerySARS-CoV-1 modulates host translation machineryViral mRNA Translation
MECANISMO DE DOENÇA

Diamond-Blackfan anemia 9

An autosomal dominant form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
1681.1 TPM
Linfócitos
1474.9 TPM
Fibroblastos
1208.3 TPM
Cervix Ectocervix
1176.5 TPM
Cervix Endocervix
1060.4 TPM
OUTRAS DOENÇAS (2)
Diamond-Blackfan anemia 9Diamond-Blackfan anemia
HGNC:10383UniProt:P46783
RPS15ASmall ribosomal subunit protein uS8Disease-causing germline mutation(s) inDesconhecido
FUNÇÃO

Component of the small ribosomal subunit (PubMed:23636399). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome (PubMed

LOCALIZAÇÃO

CytoplasmNucleus, nucleolus

VIAS BIOLÓGICAS (10)
Formation of a pool of free 40S subunitsMajor pathway of rRNA processing in the nucleolus and cytosolSARS-CoV-2 modulates host translation machinerySARS-CoV-1 modulates host translation machineryViral mRNA Translation
MECANISMO DE DOENÇA

Diamond-Blackfan anemia 20

A form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies. DBA20 inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
439.4 TPM
Linfócitos
414.4 TPM
Cervix Ectocervix
296.5 TPM
Cervix Endocervix
279.4 TPM
Fibroblastos
273.0 TPM
OUTRAS DOENÇAS (2)
Diamond-Blackfan anemia 20Diamond-Blackfan anemia
HGNC:10389UniProt:P62244
THPOThrombopoietinCandidate gene tested inTolerante
FUNÇÃO

Lineage-specific cytokine affecting the proliferation and maturation of megakaryocytes from their committed progenitor cells. It acts at a late stage of megakaryocyte development. It may be the major physiological regulator of circulating platelets

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (1)
Platelet Aggregation (Plug Formation)
MECANISMO DE DOENÇA

Thrombocythemia 1

A myeloproliferative disorder characterized by excessive platelet production, resulting in increased numbers of circulating platelets. It can be associated with spontaneous hemorrhages and thrombotic episodes.

EXPRESSÃO TECIDUAL(Ubíquo)
Fígado
19.4 TPM
Cerebelo
9.8 TPM
Cérebro - Hemisfério cerebelar
9.7 TPM
Cervix Endocervix
7.6 TPM
Útero
7.4 TPM
OUTRAS DOENÇAS (7)
thrombocytopenia 9thrombocythemia 1amegakaryocytic thrombocytopenia, congenital, 2congenital amegakaryocytic thrombocytopenia 1
HGNC:11795UniProt:P40225
RPS17Small ribosomal subunit protein eS17Disease-causing germline mutation(s) inDesconhecido
FUNÇÃO

Component of the small ribosomal subunit (PubMed:23636399). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding,

LOCALIZAÇÃO

CytoplasmNucleus, nucleolus

VIAS BIOLÓGICAS (10)
Formation of a pool of free 40S subunitsMajor pathway of rRNA processing in the nucleolus and cytosolSARS-CoV-2 modulates host translation machinerySARS-CoV-1 modulates host translation machineryViral mRNA Translation
MECANISMO DE DOENÇA

Diamond-Blackfan anemia 4

An autosomal dominant form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of developing leukemia. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
1429.7 TPM
Ovário
1346.7 TPM
Fibroblastos
1110.5 TPM
Skin Not Sun Exposed Suprapubic
923.2 TPM
Cervix Ectocervix
921.4 TPM
OUTRAS DOENÇAS (2)
Diamond-Blackfan anemia 4Diamond-Blackfan anemia
HGNC:10397UniProt:P08708
PRF1Perforin-1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Pore-forming protein that plays a key role in granzyme-mediated programmed cell death, and in defense against virus-infected or neoplastic cells (PubMed:20889983, PubMed:21037563, PubMed:24558045, PubMed:9058810, PubMed:9164947). Plays an important role in killing other cells that are recognized as non-self by the immune system, e.g. in transplant rejection or some forms of autoimmune disease (PubMed:9058810). Can insert into the membrane of target cells in its calcium-bound form, oligomerize an

LOCALIZAÇÃO

Cytolytic granuleSecretedCell membraneEndosome lumen

VIAS BIOLÓGICAS (1)
Nuclear events stimulated by ALK signaling in cancer
MECANISMO DE DOENÇA

Hemophagocytic lymphohistiocytosis, familial, 2

A rare disorder characterized by immune dysregulation with hypercytokinemia, defective function of natural killer cell, and massive infiltration of several organs by activated lymphocytes and macrophages. The clinical features of the disease include fever, hepatosplenomegaly, cytopenia, and less frequently neurological abnormalities ranging from irritability and hypotonia to seizures, cranial nerve deficits and ataxia.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
119.4 TPM
Baço
84.6 TPM
Pulmão
28.8 TPM
Intestino delgado
8.4 TPM
Adipose Visceral Omentum
7.5 TPM
OUTRAS DOENÇAS (6)
lymphoma, non-Hodgkin, familialfamilial hemophagocytic lymphohistiocytosis 2aplastic anemiahereditary hemophagocytic lymphohistiocytosis
HGNC:9360UniProt:P14222
IFNGInterferon gammaCandidate gene tested inTolerante
FUNÇÃO

Type II interferon produced by immune cells such as T-cells and NK cells that plays crucial roles in antimicrobial, antiviral, and antitumor responses by activating effector immune cells and enhancing antigen presentation (PubMed:16914093, PubMed:8666937). Primarily signals through the JAK-STAT pathway after interaction with its receptor IFNGR1 to affect gene regulation (PubMed:8349687). Upon IFNG binding, IFNGR1 intracellular domain opens out to allow association of downstream signaling compone

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (6)
Interferon gamma signalingIFNG signaling activates MAPKsRegulation of IFNG signalingRUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells)
MECANISMO DE DOENÇA

Aplastic anemia

A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements. It is characterized by peripheral pancytopenia and marrow hypoplasia.

EXPRESSÃO TECIDUAL(Baixa expressão)
Sangue
1.1 TPM
Baço
0.9 TPM
Pulmão
0.9 TPM
Linfócitos
0.9 TPM
Adipose Visceral Omentum
0.3 TPM
OUTRAS DOENÇAS (8)
immunodeficiency 69tuberous sclerosisidiopathic aplastic anemiatuberous sclerosis 2
HGNC:5438UniProt:P01579
PALB2Partner and localizer of BRCA2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a critical role in homologous recombination repair (HRR) through its ability to recruit BRCA2 and RAD51 to DNA breaks (PubMed:16793542, PubMed:19369211, PubMed:19423707, PubMed:22941656, PubMed:24141787, PubMed:28319063). Strongly stimulates the DNA strand-invasion activity of RAD51, stabilizes the nucleoprotein filament against a disruptive BRC3-BRC4 polypeptide and helps RAD51 to overcome the suppressive effect of replication protein A (RPA) (PubMed:20871615). Functionally cooperates wit

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (6)
Resolution of D-loop Structures through Holliday Junction IntermediatesHDR through Homologous Recombination (HRR)Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)Homologous DNA Pairing and Strand ExchangeImpaired BRCA2 binding to PALB2
MECANISMO DE DOENÇA

Breast cancer

A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
13.6 TPM
Testículo
10.3 TPM
Fibroblastos
10.2 TPM
Cérebro - Hemisfério cerebelar
8.7 TPM
Cerebelo
8.4 TPM
OUTRAS DOENÇAS (9)
Fanconi anemia complementation group NPALB2-related cancer predispositionchordomahereditary breast carcinoma
HGNC:26144UniProt:Q86YC2
FANCEFanconi anemia group E proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

As part of the Fanconi anemia (FA) complex functions in DNA cross-links repair. Required for the nuclear accumulation of FANCC and provides a critical bridge between the FA complex and FANCD2

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
PKR-mediated signaling
MECANISMO DE DOENÇA

Fanconi anemia complementation group E

A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Sun Exposed Lower leg
24.3 TPM
Skin Not Sun Exposed Suprapubic
24.1 TPM
Testículo
22.8 TPM
Artéria tibial
21.1 TPM
Vagina
16.6 TPM
OUTRAS DOENÇAS (2)
Fanconi anemia complementation group EFanconi anemia
HGNC:3586UniProt:Q9HB96
FANCIFanconi anemia group I proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays an essential role in the repair of DNA double-strand breaks by homologous recombination and in the repair of interstrand DNA cross-links (ICLs) by promoting FANCD2 monoubiquitination by FANCL and participating in recruitment to DNA repair sites (PubMed:17412408, PubMed:17460694, PubMed:17452773, PubMed:19111657, PubMed:36385258). The FANCI-FANCD2 complex binds and scans double-stranded DNA (dsDNA) for DNA damage; this complex stalls at DNA junctions between double-stranded DNA and single-s

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (2)
TP53 Regulates Transcription of DNA Repair GenesFanconi Anemia Pathway
MECANISMO DE DOENÇA

Fanconi anemia complementation group I

A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
62.0 TPM
Testículo
42.1 TPM
Fibroblastos
14.0 TPM
Esôfago - Mucosa
9.7 TPM
Skin Sun Exposed Lower leg
7.5 TPM
OUTRAS DOENÇAS (2)
Fanconi anemia complementation group IFanconi anemia
HGNC:25568UniProt:Q9NVI1
GATA1Erythroid transcription factorCandidate gene tested inAltamente restrito
FUNÇÃO

Transcriptional activator or repressor which serves as a general switch factor for erythroid development (PubMed:35030251). It binds to DNA sites with the consensus sequence 5'-[AT]GATA[AG]-3' within regulatory regions of globin genes and of other genes expressed in erythroid cells. Activates the transcription of genes involved in erythroid differentiation of K562 erythroleukemia cells, including HBB, HBG1/2, ALAS2 and HMBS (PubMed:24245781)

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (3)
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet functionRUNX1 regulates transcription of genes involved in differentiation of HSCsFactors involved in megakaryocyte development and platelet production
MECANISMO DE DOENÇA

X-linked dyserythropoietic anemia and thrombocytopenia

Disorder characterized by erythrocytes with abnormal size and shape, and paucity of platelets in peripheral blood. The bone marrow contains abundant and abnormally small megakaryocytes.

EXPRESSÃO TECIDUAL(Tecido-específico)
Sangue
25.8 TPM
Pulmão
3.7 TPM
Testículo
3.6 TPM
Baço
1.9 TPM
Pituitária
0.8 TPM
OUTRAS DOENÇAS (10)
transient myeloproliferative syndromethrombocytopenia, X-linked, with or without dyserythropoietic anemiahemolytic anemia due to erythrocyte adenosine deaminase overproductionX-linked dyserythropoetic anemia with abnormal platelets and neutropenia
HGNC:4170UniProt:P15976
SLX4Structure-specific endonuclease subunit SLX4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Regulatory subunit that interacts with and increases the activity of different structure-specific endonucleases. Has several distinct roles in protecting genome stability by resolving diverse forms of deleterious DNA structures originating from replication and recombination intermediates and from DNA damage. Component of the SLX1-SLX4 structure-specific endonuclease that resolves DNA secondary structures generated during DNA repair and recombination. Has endonuclease activity towards branched DN

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (2)
Resolution of D-loop Structures through Holliday Junction IntermediatesFanconi Anemia Pathway
MECANISMO DE DOENÇA

Fanconi anemia complementation group P

A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. Some individuals affected by Fanconi anemia of complementation group P have skeletal anomalies.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
28.6 TPM
Testículo
27.2 TPM
Cérebro - Hemisfério cerebelar
24.9 TPM
Linfócitos
12.8 TPM
Pituitária
8.1 TPM
OUTRAS DOENÇAS (2)
Fanconi anemia complementation group PFanconi anemia
HGNC:23845UniProt:Q8IY92
RPL9Large ribosomal subunit protein uL6Candidate gene tested inDesconhecido
FUNÇÃO

Component of the large ribosomal subunit (PubMed:23636399, PubMed:32669547). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399, PubMed:32669547)

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (10)
Formation of a pool of free 40S subunitsRibosome Quality Control (RQC) complex extracts and degrades nascent peptideMajor pathway of rRNA processing in the nucleolus and cytosolGTP hydrolysis and joining of the 60S ribosomal subunitL13a-mediated translational silencing of Ceruloplasmin expression
EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
4476.5 TPM
Linfócitos
2950.8 TPM
Cervix Ectocervix
2614.7 TPM
Cervix Endocervix
2528.6 TPM
Útero
2398.1 TPM
OUTRAS DOENÇAS (1)
Diamond-Blackfan anemia
HGNC:10369UniProt:P32969
RPL27Large ribosomal subunit protein eL27Disease-causing germline mutation(s) inDesconhecido
FUNÇÃO

Component of the large ribosomal subunit (PubMed:12962325, PubMed:23636399, PubMed:25901680, PubMed:25957688, PubMed:32669547). Required for proper rRNA processing and maturation of 28S and 5.8S rRNAs (PubMed:25424902)

LOCALIZAÇÃO

Cytoplasm, cytosolCytoplasmRough endoplasmic reticulum

VIAS BIOLÓGICAS (10)
Formation of a pool of free 40S subunitsRibosome Quality Control (RQC) complex extracts and degrades nascent peptideMajor pathway of rRNA processing in the nucleolus and cytosolGTP hydrolysis and joining of the 60S ribosomal subunitL13a-mediated translational silencing of Ceruloplasmin expression
MECANISMO DE DOENÇA

Diamond-Blackfan anemia 16

An autosomal dominant form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
1721.7 TPM
Fibroblastos
1484.6 TPM
Ovário
1462.1 TPM
Cervix Ectocervix
1216.0 TPM
Skin Not Sun Exposed Suprapubic
1200.2 TPM
OUTRAS DOENÇAS (2)
Diamond-Blackfan anemia 16Diamond-Blackfan anemia
HGNC:10328UniProt:P61353
FANCCFanconi anemia group C proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

DNA repair protein that may operate in a postreplication repair or a cell cycle checkpoint function. May be implicated in interstrand DNA cross-link repair and in the maintenance of normal chromosome stability. Upon IFNG induction, may facilitate STAT1 activation by recruiting STAT1 to IFNGR1

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (1)
PKR-mediated signaling
MECANISMO DE DOENÇA

Fanconi anemia complementation group C

A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
14.6 TPM
Cerebelo
12.3 TPM
Cérebro - Hemisfério cerebelar
12.2 TPM
Fígado
8.8 TPM
Cervix Endocervix
5.9 TPM
OUTRAS DOENÇAS (2)
Fanconi anemia complementation group CFanconi anemia
HGNC:3584UniProt:Q00597
FANCGFanconi anemia group G proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

DNA repair protein that may operate in a postreplication repair or a cell cycle checkpoint function. May be implicated in interstrand DNA cross-link repair and in the maintenance of normal chromosome stability. Candidate tumor suppressor gene

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (1)
PKR-mediated signaling
MECANISMO DE DOENÇA

Fanconi anemia complementation group G

A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
34.6 TPM
Cerebelo
29.3 TPM
Cérebro - Hemisfério cerebelar
29.1 TPM
Testículo
25.7 TPM
Cervix Endocervix
18.5 TPM
OUTRAS DOENÇAS (2)
Fanconi anemia complementation group GFanconi anemia
HGNC:3588UniProt:O15287
RPS28Small ribosomal subunit protein eS28Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Component of the small ribosomal subunit (PubMed:23636399, PubMed:25901680, PubMed:25957688). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399, PubMed:25901680, PubMed:25957688). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate wi

LOCALIZAÇÃO

Cytoplasm, cytosolCytoplasmRough endoplasmic reticulumNucleus, nucleolus

VIAS BIOLÓGICAS (10)
Formation of a pool of free 40S subunitsMajor pathway of rRNA processing in the nucleolus and cytosolSARS-CoV-2 modulates host translation machinerySARS-CoV-1 modulates host translation machineryViral mRNA Translation
MECANISMO DE DOENÇA

Diamond-Blackfan anemia 15, with mandibulofacial dysostosis

An autosomal dominant form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
1185.5 TPM
Linfócitos
1182.7 TPM
Skin Not Sun Exposed Suprapubic
999.4 TPM
Skin Sun Exposed Lower leg
975.0 TPM
Fibroblastos
896.5 TPM
OUTRAS DOENÇAS (2)
Diamond-Blackfan anemia 15 with mandibulofacial dysostosisDiamond-Blackfan anemia
HGNC:10418UniProt:P62857
SRP72Signal recognition particle subunit SRP72Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the signal recognition particle (SRP) complex, a ribonucleoprotein complex that mediates the cotranslational targeting of secretory and membrane proteins to the endoplasmic reticulum (ER) (PubMed:34020957). The SRP complex interacts with the signal sequence in nascent secretory and membrane proteins and directs them to the membrane of the ER (PubMed:34020957). The SRP complex targets the ribosome-nascent chain complex to the SRP receptor (SR), which is anchored in the ER, where SR c

LOCALIZAÇÃO

CytoplasmEndoplasmic reticulum

VIAS BIOLÓGICAS (1)
SRP-dependent cotranslational protein targeting to membrane
MECANISMO DE DOENÇA

Bone marrow failure syndrome 1

An autosomal dominant disease characterized by aplastic anemia and myelodysplasia resulting from bone marrow failure. Aplastic anemia is a form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements. Myelodysplasia is a clonal hematopoietic stem cell disorder in which immature cells in the bone marrow become malformed and dysfunctional.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
110.6 TPM
Linfócitos
100.6 TPM
Cervix Endocervix
55.2 TPM
Ovário
54.7 TPM
Artéria tibial
54.5 TPM
OUTRAS DOENÇAS (1)
autosomal dominant aplasia and myelodysplasia
HGNC:11303UniProt:O76094
RPL31Large ribosomal subunit protein eL31Candidate gene tested inDesconhecido
FUNÇÃO

Component of the large ribosomal subunit (PubMed:23636399, PubMed:32669547). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399, PubMed:32669547)

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (10)
Formation of a pool of free 40S subunitsRibosome Quality Control (RQC) complex extracts and degrades nascent peptideMajor pathway of rRNA processing in the nucleolus and cytosolGTP hydrolysis and joining of the 60S ribosomal subunitL13a-mediated translational silencing of Ceruloplasmin expression
EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
655.5 TPM
Linfócitos
513.6 TPM
Cervix Endocervix
414.7 TPM
Cervix Ectocervix
411.9 TPM
Fibroblastos
375.6 TPM
OUTRAS DOENÇAS (1)
Diamond-Blackfan anemia
HGNC:10334UniProt:P62899
CALRCalreticulinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Calcium-binding chaperone that promotes folding, oligomeric assembly and quality control in the endoplasmic reticulum (ER) via the calreticulin/calnexin cycle. This lectin interacts transiently with almost all of the monoglucosylated glycoproteins that are synthesized in the ER (PubMed:7876246). Interacts with the DNA-binding domain of NR3C1 and mediates its nuclear export (PubMed:11149926). Involved in maternal gene expression regulation. May participate in oocyte maturation via the regulation

LOCALIZAÇÃO

Endoplasmic reticulum lumenCytoplasm, cytosolSecreted, extracellular space, extracellular matrixCell surfaceSarcoplasmic reticulum lumenCytoplasmic vesicle, secretory vesicle, Cortical granuleCytolytic granule

VIAS BIOLÓGICAS (2)
Antigen Presentation: Folding, assembly and peptide loading of class I MHCER-Phagosome pathway
OUTRAS DOENÇAS (4)
thrombocythemia 1primary myelofibrosisessential thrombocythemiaBudd-Chiari syndrome
HGNC:1455UniProt:P27797
FANCBFanconi anemia group B proteinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

DNA repair protein required for FANCD2 ubiquitination

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
PKR-mediated signaling
MECANISMO DE DOENÇA

Fanconi anemia complementation group B

A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. Some severe FANCB cases manifest features of VACTERL syndrome with hydrocephalus.

EXPRESSÃO TECIDUAL(Tecido-específico)
Linfócitos
5.5 TPM
Fibroblastos
3.2 TPM
Nervo tibial
1.5 TPM
Baço
0.8 TPM
Esôfago - Mucosa
0.7 TPM
OUTRAS DOENÇAS (3)
Fanconi anemia complementation group BVACTERL with hydrocephalusFanconi anemia
HGNC:3583UniProt:Q8NB91
RPL11Large ribosomal subunit protein uL5Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Component of the ribosome, a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:19191325, PubMed:32669547). The small ribosomal subunit (SSU) binds messenger RNAs (mRNAs) and translates the encoded message by selecting cognate aminoacyl-transfer RNA (tRNA) molecules (PubMed:19191325, PubMed:32669547). The large subunit (LSU) contains the ribosomal catalytic site termed the peptidyl transferase center (PTC), which catalyzes the formation of peptide bonds

LOCALIZAÇÃO

Nucleus, nucleolusCytoplasm

VIAS BIOLÓGICAS (10)
Formation of a pool of free 40S subunitsRibosome Quality Control (RQC) complex extracts and degrades nascent peptideMajor pathway of rRNA processing in the nucleolus and cytosolGTP hydrolysis and joining of the 60S ribosomal subunitL13a-mediated translational silencing of Ceruloplasmin expression
MECANISMO DE DOENÇA

Diamond-Blackfan anemia 7

An autosomal dominant form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
1874.9 TPM
Linfócitos
1495.0 TPM
Cervix Ectocervix
1222.1 TPM
Fibroblastos
1192.8 TPM
Cervix Endocervix
1160.8 TPM
OUTRAS DOENÇAS (2)
Diamond-Blackfan anemia 7Diamond-Blackfan anemia
HGNC:10301UniProt:P62913
TERCCandidate gene tested inDesconhecido
LOCALIZAÇÃO

VIAS REACTOME (1)
OUTRAS DOENÇAS (5)
dyskeratosis congenita, autosomal dominant 1pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2dyskeratosis congenitaidiopathic aplastic anemia
HGNC:11727
RPL8Large ribosomal subunit protein uL2Candidate gene tested inDesconhecido
FUNÇÃO

Component of the large ribosomal subunit. The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (10)
Formation of a pool of free 40S subunitsRibosome Quality Control (RQC) complex extracts and degrades nascent peptideMajor pathway of rRNA processing in the nucleolus and cytosolGTP hydrolysis and joining of the 60S ribosomal subunitL13a-mediated translational silencing of Ceruloplasmin expression
EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
3861.7 TPM
Linfócitos
2796.7 TPM
Cervix Ectocervix
2570.8 TPM
Skin Not Sun Exposed Suprapubic
2459.7 TPM
Cervix Endocervix
2437.5 TPM
OUTRAS DOENÇAS (1)
Diamond-Blackfan anemia
HGNC:10368UniProt:P62917
JAK2Tyrosine-protein kinase JAK2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Non-receptor tyrosine kinase involved in various processes such as cell growth, development, differentiation or histone modifications. Mediates essential signaling events in both innate and adaptive immunity. In the cytoplasm, plays a pivotal role in signal transduction via its association with type I receptors such as growth hormone (GHR), prolactin (PRLR), leptin (LEPR), erythropoietin (EPOR), thrombopoietin receptor (MPL/TPOR); or type II receptors including IFN-alpha, IFN-beta, IFN-gamma and

LOCALIZAÇÃO

Endomembrane systemCytoplasmNucleus

VIAS BIOLÓGICAS (10)
Interleukin-20 family signalingRAF activationSignaling downstream of RAS mutantsSignaling by moderate kinase activity BRAF mutantsParadoxical activation of RAF signaling by kinase inactive BRAF
EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
68.9 TPM
Aorta
46.9 TPM
Artéria coronária
31.6 TPM
Tecido adiposo
20.8 TPM
Nervo tibial
20.0 TPM
OUTRAS DOENÇAS (9)
thrombocythemia 3acquired polycythemia veraprimary myelofibrosisprimary familial polycythemia due to EPO receptor mutation
HGNC:6192UniProt:O60674
RPL35ALarge ribosomal subunit protein eL33Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Component of the large ribosomal subunit (PubMed:23636399, PubMed:32669547). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399, PubMed:32669547). Required for the proliferation and viability of hematopoietic cells (PubMed:18535205)

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (10)
Formation of a pool of free 40S subunitsRibosome Quality Control (RQC) complex extracts and degrades nascent peptideMajor pathway of rRNA processing in the nucleolus and cytosolGTP hydrolysis and joining of the 60S ribosomal subunitL13a-mediated translational silencing of Ceruloplasmin expression
MECANISMO DE DOENÇA

Diamond-Blackfan anemia 5

An autosomal dominant form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
1291.9 TPM
Cervix Endocervix
814.4 TPM
Linfócitos
811.9 TPM
Cervix Ectocervix
777.8 TPM
Útero
683.3 TPM
OUTRAS DOENÇAS (2)
Diamond-Blackfan anemia 5Diamond-Blackfan anemia
HGNC:10345UniProt:P18077
RPS19Small ribosomal subunit protein eS19Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Component of the small ribosomal subunit (PubMed:23636399). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399). Required for pre-rRNA processing and maturation of 40S ribosomal subunits (PubMed:16990592). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and riboso

LOCALIZAÇÃO

CytoplasmNucleus, nucleolus

VIAS BIOLÓGICAS (10)
Formation of a pool of free 40S subunitsMajor pathway of rRNA processing in the nucleolus and cytosolSARS-CoV-2 modulates host translation machinerySARS-CoV-1 modulates host translation machineryViral mRNA Translation
MECANISMO DE DOENÇA

Diamond-Blackfan anemia 1

An autosomal dominant form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of developing leukemia. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
934.3 TPM
Ovário
836.5 TPM
Fibroblastos
780.7 TPM
Skin Sun Exposed Lower leg
685.7 TPM
Skin Not Sun Exposed Suprapubic
670.9 TPM
OUTRAS DOENÇAS (2)
Diamond-Blackfan anemia 1Diamond-Blackfan anemia
HGNC:10402UniProt:P39019
FANCAFanconi anemia group A proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

DNA repair protein that may operate in a postreplication repair or a cell cycle checkpoint function. May be involved in interstrand DNA cross-link repair and in the maintenance of normal chromosome stability

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (1)
PKR-mediated signaling
MECANISMO DE DOENÇA

Fanconi anemia, complementation group A

A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair.

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
25.2 TPM
Linfócitos
22.3 TPM
Fibroblastos
6.8 TPM
Baço
4.8 TPM
Cerebelo
4.7 TPM
OUTRAS DOENÇAS (2)
Fanconi anemia complementation group AFanconi anemia
HGNC:3582UniProt:O15360
ACDAdrenocortical dysplasia protein homologCandidate gene tested inTolerante
FUNÇÃO

Component of the shelterin complex (telosome) that is involved in the regulation of telomere length and protection. Shelterin associates with arrays of double-stranded TTAGGG repeats added by telomerase and protects chromosome ends. Without its protective activity, telomeres are no longer hidden from the DNA damage surveillance and chromosome ends are inappropriately processed by DNA repair pathways. Promotes binding of POT1 to single-stranded telomeric DNA. Modulates the inhibitory effects of P

LOCALIZAÇÃO

NucleusChromosome, telomere

VIAS BIOLÓGICAS (10)
DNA Damage/Telomere Stress Induced SenescencePackaging Of Telomere EndsMeiotic synapsisInhibition of DNA recombination at telomereTelomere C-strand (Lagging Strand) Synthesis
MECANISMO DE DOENÇA

Dyskeratosis congenita, autosomal dominant, 6

A form of dyskeratosis congenita, a rare multisystem disorder caused by defective telomere maintenance. It is characterized by progressive bone marrow failure, and the clinical triad of reticulated skin hyperpigmentation, nail dystrophy, and mucosal leukoplakia. Common but variable features include premature graying, aplastic anemia, low platelets, osteoporosis, pulmonary fibrosis, and liver fibrosis among others. Early mortality is often associated with bone marrow failure, infections, fatal pulmonary complications, or malignancy.

OUTRAS DOENÇAS (4)
dyskeratosis congenita, autosomal dominant 6inherited aplastic anemiafamilial melanomaHoyeraal-Hreidarsson syndrome
HGNC:25070UniProt:Q96AP0

Medicamentos e terapias

RUXOLITINIB PHOSPHATEPhase 4

Mecanismo: Tyrosine-protein kinase JAK2 inhibitor

FEDRATINIB HYDROCHLORIDEPhase 4

Mecanismo: Tyrosine-protein kinase JAK2 inhibitor

PACRITINIB CITRATEPhase 4

Mecanismo: Tyrosine-protein kinase receptor FLT3 inhibitor

ECULIZUMABPhase 4

Mecanismo: Complement C5 inhibitor

RAVULIZUMABPhase 4

Mecanismo: Complement C5 inhibitor

PEGCETACOPLANPhase 4

Mecanismo: Complement C3 inhibitor

MOMELOTINIBPhase 3

Mecanismo: Tyrosine-protein kinase JAK2 inhibitor

PEGINTERFERON ALFA-2APhase 3

Mecanismo: Interferon alpha/beta receptor agonist

PEGINTERFERON ALFA-2BPhase 3

Mecanismo: Interferon alpha/beta receptor agonist

FEDRATINIBPhase 3

Mecanismo: Tyrosine-protein kinase receptor FLT3 inhibitor

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

378 variantes patogênicas registradas no ClinVar.

🧬 TET2: NM_001127208.3(TET2):c.3691_3697del (p.Leu1231fs) ()
🧬 TET2: NM_001127208.3(TET2):c.4146_4147del (p.His1382fs) ()
🧬 TET2: NM_001127208.3(TET2):c.2079del (p.Lys693fs) ()
🧬 TET2: NM_001127208.3(TET2):c.2249_2252del (p.Ile750fs) ()
🧬 TET2: NM_001127208.3(TET2):c.3500+2del ()
Ver todas no ClinVar

Vias biológicas (Reactome)

141 vias biológicas associadas aos genes desta condição.

TET1,2,3 and TDG demethylate DNA Specification of primordial germ cells Telomere Extension By Telomerase Formation of the beta-catenin:TCF transactivating complex Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence L13a-mediated translational silencing of Ceruloplasmin expression Peptide chain elongation SRP-dependent cotranslational protein targeting to membrane Viral mRNA Translation Selenocysteine synthesis Major pathway of rRNA processing in the nucleolus and cytosol Formation of a pool of free 40S subunits GTP hydrolysis and joining of the 60S ribosomal subunit Eukaryotic Translation Termination Regulation of expression of SLITs and ROBOs Response of EIF2AK4 (GCN2) to amino acid deficiency Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA Translation initiation complex formation Formation of the ternary complex, and subsequently, the 43S complex Ribosomal scanning and start codon recognition SARS-CoV-1 modulates host translation machinery SARS-CoV-2 modulates host translation machinery Meiotic synapsis SUMOylation of DNA damage response and repair proteins HDR through Single Strand Annealing (SSA) HDR through Homologous Recombination (HRR) Metalloprotease DUBs Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks Resolution of D-loop Structures through Holliday Junction Intermediates Nonhomologous End-Joining (NHEJ) Homologous DNA Pairing and Strand Exchange Processing of DNA double-strand break ends Presynaptic phase of homologous DNA pairing and strand exchange TP53 Regulates Transcription of DNA Repair Genes Regulation of TP53 Activity through Phosphorylation G2/M DNA damage checkpoint Neddylation Transcriptional Regulation by E2F6 Meiotic recombination Defective DNA double strand break response due to BRCA1 loss of function Defective DNA double strand break response due to BARD1 loss of function Defective homologous recombination repair (HRR) due to BRCA1 loss of function Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function Impaired BRCA2 binding to RAD51 Impaired BRCA2 binding to PALB2 KEAP1-NFE2L2 pathway Platelet Aggregation (Plug Formation) Translesion synthesis by REV1 Translesion synthesis by POLK Translesion synthesis by POLI Cytosolic iron-sulfur cluster assembly DNA Damage/Telomere Stress Induced Senescence HDR through MMEJ (alt-NHEJ) Sensing of DNA Double Strand Breaks Factors involved in megakaryocyte development and platelet production Fanconi Anemia Pathway PKR-mediated signaling Surfactant metabolism Neutrophil degranulation Dengue Virus-Host Interactions Formation of Incision Complex in GG-NER Dual Incision in GG-NER Dual incision in TC-NER Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal Separation of Sister Chromatids Resolution of Sister Chromatid Cohesion RHO GTPases Activate Formins Mitotic Prometaphase EML4 and NUDC in mitotic spindle formation Attachment of GPI anchor to uPAR Impaired BRCA2 translocation to the nucleus Impaired BRCA2 binding to SEM1 (DSS1) rRNA modification in the nucleus and cytosol Regulation of KIT signaling Negative regulation of FLT3 Synthesis of active ubiquitin: roles of E1 and E2 enzymes Synthesis of glycosylphosphatidylinositol (GPI) Nuclear events stimulated by ALK signaling in cancer Interferon gamma signaling Regulation of IFNG signaling RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation IFNG signaling activates MAPKs Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function RUNX1 regulates transcription of genes involved in differentiation of HSCs ER-Phagosome pathway Assembly of Viral Components at the Budding Site Scavenging by Class A Receptors Scavenging by Class F Receptors ATF6 (ATF6-alpha) activates chaperone genes Calnexin/calreticulin cycle Antigen Presentation: Folding, assembly and peptide loading of class I MHC Maturation of DENV proteins Telomere Maintenance Protein hydroxylation Interleukin-6 signaling MAPK3 (ERK1) activation MAPK1 (ERK2) activation Prolactin receptor signaling Signaling by SCF-KIT Signaling by Leptin RMTs methylate histone arginines Interleukin-3, Interleukin-5 and GM-CSF signaling RAF activation RAF/MAP kinase cascade Interleukin-4 and Interleukin-13 signaling IL-6-type cytokine receptor ligand interactions Signaling by moderate kinase activity BRAF mutants Signaling by BRAF and RAF1 fusions Paradoxical activation of RAF signaling by kinase inactive BRAF Cyclin D associated events in G1 Interleukin-20 family signaling Interleukin-35 Signalling Signaling by Erythropoietin Interleukin-12 signaling Interleukin-23 signaling Interleukin-27 signaling Erythropoietin activates Phosphoinositide-3-kinase (PI3K) Erythropoietin activates Phospholipase C gamma (PLCG) Erythropoietin activates STAT5 Erythropoietin activates RAS Interleukin receptor SHC signaling Signaling downstream of RAS mutants Recognition and association of DNA glycosylase with site containing an affected pyrimidine Cleavage of the damaged pyrimidine Recognition and association of DNA glycosylase with site containing an affected purine Cleavage of the damaged purine Packaging Of Telomere Ends Polymerase switching on the C-strand of the telomere Processive synthesis on the C-strand of the telomere Telomere C-strand (Lagging Strand) Synthesis Telomere C-strand synthesis initiation Removal of the Flap Intermediate from the C-strand Inhibition of DNA recombination at telomere

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado6
3Fase 35
2Fase 21
·Pré-clínico3
Medicamentos catalogadosEnsaios clínicos· 10 medicamentos · 5 ensaios
✓ Aprovados — podem ser usados hoje
RUXOLITINIB PHOSPHATEFEDRATINIB HYDROCHLORIDEPACRITINIB CITRATEECULIZUMABRAVULIZUMABPEGCETACOPLAN
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Anemia aplásica rara

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

2 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

0 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Towards evolutionary guided precision medicine of acute myeloid leukemia and Fanconi anemia associated bone marrow failure.

Stem cells translational medicine2026 Feb 25

Carcinogenesis and acquisition of multidrug resistance within established cancers are both multistep evolutionary processes in which stem cells play a role. This perspective will briefly review two corresponding theoretical constructs under development. Efficiency of carcinogenesis (EOC) considers multistep carcinogenesis and predicts the effect of differing dynamics on the efficiency of generating a transformed founder cell. EOC has been applied to evaluation of the role of genetic instability in carcinogenesis. Dynamic precision medicine (DPM) is a method for providing personalized treatment sequences for cancer while explicitly considering intracancer subclonal heterogeneity and evolutionary dynamics (growth and evolutionary rates). It adapts therapy frequently and proactively by anticipating the kinetics of multidrug resistance prior to its detection, and prioritizing its prevention. Simulations suggest potential to substantially increase survival and cure rates across a broad range of clinical presentations. Both of these problems implicate very small subclones within stem cell and/or differentiated compartments, and evolution may occur over months to years. We describe novel experimental technologies for quantifying longitudinal dynamics of very large numbers of cells for prolonged periods, allowing detection and tracking of rare events and their evolution over time. We further highlight two potential applications. In Fanconi anemia, optimal treatment sequences for minimizing bone marrow failure while not increasing the risk of leukemia may be designed using EOC and DPM and tested in laboratory models. In refractory acute myeloid leukemia, high throughput molecular characterization and drug sensitivity screening of subclones is showing clinical promise, and may be further optimized with DPM.

#2

Differential genetic analysis of ectrodactyly in a Fanconi anemia pedigree with FANCA mutations.

MedScience2026 Feb 14

Fanconi anemia (FA; OMIM: 227650) is a rare genetic disorder characterized by bone marrow failure, congenital anomalies, and cancer predisposition. While FANCA mutations account for most FA cases, phenotypic overlap with other disorders complicates diagnosis. This study analyzes molecular diagnostic pathways for FANCA-related FA and establishes a hereditary differential diagnosis for ectrodactyly. A Chinese FA family clinical phenotype was collected. The proband and father underwent whole-genome sequencing. Copy number variations (CNVs) in FANCA were assessed by genomic qPCR. Functional characterization of the EHMT1 variant included minigene splicing assays, RT-qPCR and Western blotting on peripheral blood samples. The proband showed pancytopenia and bone marrow hypoplasia, suggesting aplastic anemia. Sequencing analysis identified two FANCA mutations, NM_000135.4: c.154C>T and NC_000016.9: g.89865477_89895212del, which caused partial protein deletion. Subsequent pedigree analysis revealed that the affected individuals of the proband's paternal lineage, who exhibited ectrodactyly, were heterozygous for the EHMT1 c.2382 + 1750G>A variant (NM 024757.5) and showed significantly reduced EHMT1 mRNA expression, demonstrating complete genotype-phenotype co-segregation. Furthermore, Western blot revealed reduced H3K9me2 and decreased intensity of a ∼100 kDa EHMT1-reactive band in the proband's father. The newly identified g.89865477_89895212del mutation enriches the FANCA gene mutant spectrum. Additionally, the EHMT1 c.2382 + 1750G>A variant co-segregates with ectrodactyly and is accompanied by significantly reduced EHMT1 mRNA expression.

#3

Case Report: SLC52A2 variants cause Brown-Vialetto-Van Laere syndrome type 2, characterized by pure red cell aplastic anemia: clinical and genetic features of three Chinese children.

Frontiers in pediatrics2026

To report three Chinese pediatric cases of Brown-Vialetto-Van Laere syndrome type 2 (BVVLS2) presenting with pure red cell aplasia (PRCA) as the core manifestation, and to analyze their clinical features, molecular basis, and response to riboflavin therapy. We conducted a retrospective analysis of three pediatric cases, integrating detailed clinical phenotyping with comprehensive genetic analysis (including whole-exome/targeted sequencing, Sanger validation, and ACMG-based variant interpretation). To elucidate genotype-phenotype correlations, we interpreted these findings in the context of a literature review. All three patients carried compound heterozygous variants in the SLC52A2 gene. Each exhibited early-onset PRCA (onset age: 2 days to 6 months; hemoglobin: 29-67 g/L) and progressive neurodegeneration, including motor regression, axonal peripheral neuropathy, and sensorineural hearing loss. Riboflavin supplementation led to normalization of hemoglobin levels within four weeks and marked improvement in neurological function. This case series provides detailed longitudinal data on riboflavin-responsive PRCA as a core presenting feature of BVVLS2 and reports rare SLC52A2 variants in the Chinese population. Early riboflavin treatment effectively reversed anemia and partially improved neurological deficits, which may inform a new diagnostic and therapeutic approach for unexplained PRCA accompanied by neurodegenerative features.

#4

Pregnancy-induced aplastic anaemia with platelet refractoriness: clinical insights.

BMJ case reports2026 Jan 07

Aplastic anaemia is a rare and potentially life-threatening condition that can worsen during pregnancy. Its management poses unique challenges due to risks of haemorrhage, infection and transfusion complications. We present a case of a second gravida woman in her 30s with progressive bicytopenia starting in the second trimester. Despite multiple transfusions, her platelet counts remained critically low due to suspected platelet refractoriness. Bone marrow biopsy confirmed aplastic anaemia. She was managed with supportive care and steroid pulse therapy, and delivery was planned at term. An emergency caesarean was performed for arrest of labour under general anaesthesia. The patient made a gradual recovery postnatally without requiring bone marrow transplantation. Her counts normalised by 3 months postpartum, supporting the diagnosis of pregnancy-induced reversible aplastic anaemia. This case highlights the importance of multidisciplinary management and the challenges of transfusion refractoriness in resource-limited settings.

#5

Acute severe cholestatic hepatitis and lymphopenia characterize pediatric hepatitis-associated aplastic anemia.

Journal of pediatric gastroenterology and nutrition2026 Feb

Hepatitis-associated aplastic anemia (HAAA) is described as acute severe hepatitis of unknown origin followed by bone marrow failure (BMF). We aimed to provide a comprehensive picture of pediatric HAAA. Two-center retrospective analysis was performed using data from children diagnosed with acquired BMF, including severe aplastic anemia (SAA) and myelodysplastic syndrome type refractory cytopenia of childhood (RCC). The assessment of the subcohort of HAAA included clinical features indicative of diagnosis and disease progression, with additional data from previously published case series. Cohort comprised 62 children with acquired BMF and 22 children with HAAA. Median age of HAAA patients was 13.5 years. Potentially triggering viral infections were detected in 45%. The median interval from hepatitis onset to cytopenia was 3 weeks. All cases presented with severe hepatitis (median alanine transaminase 2127 U/L) and all but one with hyperbilirubinemia (median bilirubin 15.3 mg/dL). Coagulopathy was variable (median international normalized ratio 1.5). Four patients (18%) developed acute liver failure, two (9%) required liver transplantation. Hepatic parameters normalized within a median of 8.5 weeks. There was no statistically significant difference in the course of hepatitis between patients with SAA and RCC. Early lymphopenia was a key finding in patients with HAAA, progressing from a median of 905/µL at hepatitis onset to 530/µL within 4 weeks. HAAA occurs in both SAA and RCC. Most cases present with severe acute cholestatic hepatitis and variable coagulopathy. Hepatic recovery is common. Lymphopenia at disease onset is frequent and may serve as a diagnostic marker.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC1 artigos no totalmostrando 200

2026

Late-onset combined immunodeficiency and bone marrow failure in severe autoimmune hepatitis: a case report.

Journal of medical case reports
2026

Successful Treatment of Aplastic Anemia With Eltrombopag During Pregnancy: A Short Report.

EJHaem
2026

Towards evolutionary guided precision medicine of acute myeloid leukemia and Fanconi anemia associated bone marrow failure.

Stem cells translational medicine
2026

Severe aplastic anemia concurrent with lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia: A case report.

Internal medicine (Tokyo, Japan)
2026

Parvovirus B19-induced aplastic crisis in a kidney transplant recipient.

Journal of infection in developing countries
2026

Differential genetic analysis of ectrodactyly in a Fanconi anemia pedigree with FANCA mutations.

MedScience
2026

Case Report: SLC52A2 variants cause Brown-Vialetto-Van Laere syndrome type 2, characterized by pure red cell aplastic anemia: clinical and genetic features of three Chinese children.

Frontiers in pediatrics
2026

NGS identifies novel HLA-DQA1 and DPB1 associations with aplastic anemia in the Kazakhstani population.

Frontiers in immunology
2026

Assessment of characteristics and treatment patterns of adult patients with acquired aplastic anemia in Turkiye (PLANE-TR).

Annals of hematology
2025

COEXISTENCE OF APLASTIC ANEMIA AND PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: DIAGNOSTIC CHALLENGES AND THERAPEUTIC STRATEGIES - CASE REPORT.

Georgian medical news
2026

Neurofibromatosis type I -related severe aplastic anemia: an unusual association with a complicated bone marrow transplantation course.

Annals of hematology
2026

Clinical characteristics and treatment outcomes in thymoma- related aplastic anemia: a case report and literature review.

Journal of cardiothoracic surgery
2026

Machine learning mortality prediction model for cyclosporine therapy in pediatric aplastic anemia.

Annals of hematology
2026

A Rare Case of Co-occurring Fanconi Anemia and Primary Ciliary Dyskinesia.

Turkish journal of haematology : official journal of Turkish Society of Haematology
2026

A Rare Case of Disseminated Mycoplasma pneumoniae Infection Spreading from a Pelvic Lesion to a Psoas Muscle Abscess.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2026

A meta-analysis of immunosuppressive and Pharmacological therapies in aplastic anaemia with and without Indigenous equine antithymocyte globulin (eATG).

Annals of hematology
2026

Excellent outcomes in children after haematopoietic stem cell transplantation for hepatitis-associated aplastic anaemia following liver transplantation.

British journal of haematology
2026

Evaluating the Effectiveness of Early Genetic Screening for Fanconi Anemia in High-Risk Pediatric Populations.

Molecular genetics & genomic medicine
2026

Pregnancy-induced aplastic anaemia with platelet refractoriness: clinical insights.

BMJ case reports
2026

Carbamazepine-induced aplastic anemia: A rare reported adverse drug reaction.

Indian journal of pharmacology
2026

A rare case of dyskeratosis congenita with DKC1 mutation presenting initially as thrombocytopenia: Case report.

Medicine
2026

Efficacy and safety of avatrombopag in aplastic anemia: a comprehensive review of clinical evidence.

Therapeutic advances in hematology
2026

Mycoplasma pneumoniae pneumonia associated with severe neutropenia.

La Revue de medecine interne
2025

Avatrombopag in immune thrombocytopenia and beyond: Current evidence and emerging perspectives.

Blood reviews
2025

Molecular classification and outcomes in pediatric aplastic anemia with myeloid neoplasm-associated gene variants.

Frontiers in pediatrics
2026

A De Novo Splicing Mutation of SRP72 in Bone Marrow Failure Syndrome Type 1: Case Report and Review of the Literature.

Molecular genetics & genomic medicine
2025

Blastic plasmacytoid dendritic cell neoplasm (BPDCN): international, multi-center collaboration and global registry program.

Discover oncology
2025

Parvovirus B19-Induced Aplastic Crisis and Hemophagocytic Lymphohistiocytosis in a Child With Hereditary Spherocytosis.

Cureus
2025

Evaluating the causal role of circulating inflammatory cytokines and plasma metabolites on aplastic anemia.

Medicine
2025

Dental Manifestations and Clinical Implications of Diamond-Blackfan Anemia.

Journal of dentistry for children (Chicago, Ill.)
2026

Acute severe cholestatic hepatitis and lymphopenia characterize pediatric hepatitis-associated aplastic anemia.

Journal of pediatric gastroenterology and nutrition
2025

Efficacy and influencing factors of immunosuppressive therapy combined with or without eltrombopag in children with severe aplastic anemia.

Frontiers in medicine
2025

Calcineurin inhibitor and eltrombopag combination for acquired aplastic anemia: results from a large national database.

Therapeutic advances in hematology
2025

Rotational Thromboelastometry (ROTEM)-Assisted Anaesthetic Management of a Parturient With Paroxysmal Nocturnal Haemoglobinuria and Aplastic Anaemia for Caesarean Section: A Case Report.

Cureus
2025

Vaginoscopy approach with Mechanical Tissue Removal System for AUB inPediatric Aplastic Anemia: a case report.

BMC surgery
2025

Metabolic reprogramming in Fanconi anemia: Evidence of compromised glucose oxidation, enhanced ketogenesis, and metabolic inflexibility.

Science advances
2025

Predicting secondary myeloid neoplasms in acquired aplastic anemia using machine learning models.

Blood neoplasia
2025

A clinical presentation of rhino-orbito-cerebral mucormycosis in a patient with aplastic anemia: a case report.

Journal of medical case reports
2025

Hemophagocytic lymphohistiocytosis in the context of hepatitis-associated severe aplastic anemia: A case report.

Medicine
2026

Fancl-mutant mice reveal central role of monoubiquitination in Fanconi anemia and a model for therapeutic gene editing.

Blood advances
2025

Autoimmune aplastic anemia- a rare and devastating presentation of Systemic Lupus Erythematosus - a case report.

BMC rheumatology
2026

DNA Methylation Episignature as a Novel Diagnostic Tool for Diamond-Blackfan Anemia Syndrome.

American journal of hematology
2025

Hepatic Sinusoidal Obstruction Syndrome Secondary to Aplastic Anemia/Paroxysmal Nocturnal Hemoglobinuria Syndrome: A Rare Case.

Diagnostics (Basel, Switzerland)
2025

Pediatric Hepatitis-Associated Aplastic Anemia.

Pediatric annals
2025

Osimertinib-induced aplastic anemia after curative surgery for EGFR-mutant lung adenocarcinoma.

Respiratory medicine case reports
2025

A Rare Case of Anti-glutamic Acid Decarboxylase 65 Autoimmune Encephalitis Followed by Acute Graft-Versus-Host Disease in Simultaneous Kidney and Pancreas Transplant.

Kidney medicine
2026

Immuno-microbial crosstalk in aplastic anemia: Role of gut and viral triggers.

Microbial pathogenesis
2025

Aplastic Anemia in Focus: Insights into Diagnosis and Emerging Therapies.

Annals of African medicine
2025

Loss of Fanconi anemia proteins causes a reliance on lysosomal exocytosis.

Cell death & disease
2025

Refractory severe aplastic anemia in a child: treatment failure and access barriers in a low-resource setting.

Annals of medicine and surgery (2012)
2025

A Rare Case of Atezolizumab-Induced Very Severe Aplastic Anemia.

Cureus
2026

Decitabine-cedazuridine in patients with MDS and TP53 mutations.

Blood advances
2025

Final safety and efficacy results from a phase 1/2 study of tagraxofusp, a CD123-targeted therapy, for myelofibrosis.

Blood neoplasia
2025

Disparities in real-world treatment patterns of hypomethylating agents among patients with MDS in the United States.

Blood neoplasia
2025

Aplastic anemia following high-voltage electrical injury: A case report.

Trauma case reports
2025

Congenital Anemia Due to Erythropoietin Gene Mutation Presenting With Diamond-Blackfan Anemia-like features.

Journal of investigative medicine high impact case reports
2025

Early and Long-Lasting Hematologic Recovery in a Young Adult With Severe Aplastic Anemia Treated With Romiplostim, Horse-Anti-Thymocyte Globulin (ATG), and Cyclosporine A: A Case Report.

Cureus
2025

Case report: Spontaneous remission of severe aplastic anemia mediated by mutant hematopoietic stem cells evading T-cell attack.

Frontiers in immunology
2025

Ending diagnostic odyssey by reanalysis of whole exome sequencing data: reclassification of suspected Fanconi anemia cases to dyskeratosis congenita and Diamond-Blackfan anemia.

Orphanet journal of rare diseases
2025

Research Communication: Prevalence of Asymptomatic Premalignant Oesophageal Lesions in Patients With Fanconi Anaemia.

Alimentary pharmacology & therapeutics
2025

A Case Report of Severe Aplastic Anemia Complicated by Papillary Thyroid Carcinoma and Hashimoto's Thyroiditis.

Clinical laboratory
2025

Dynamics of Fanconi anemia protein D2 in association with nuclear lipid droplet formation.

Journal of cell science
2025

[Aplastic anemia in children: recent advances in diagnosis and treatment].

[Rinsho ketsueki] The Japanese journal of clinical hematology
2025

Pharmacovigilance assessment of drug-induced aplastic anemia: analysis of the FDA adverse event reporting system.

International journal of clinical pharmacy
2025

Mechanistic insights into alcohol-induced DNA crosslink repair by Slx4-Xpf-Ercc1 nuclease complex in the Fanconi anaemia pathway.

Communications biology
2025

Parvovirus B19-induced aplastic anemia following mechanical valve replacement.

The Journal of international medical research
2025

A de novo nonsense variant in RPS10 causes Diamond-Blackfan anaemia in an Indian patient: clinical and functional evidence.

Molecular genetics and genomics : MGG
2025

Spinal Extramedullary Hematopoiesis Causing Spinal Cord Compression in Radiation-induced Bone Marrow Aplasia: A Case Report.

Acta medica Philippina
2025

Paroxysmal Nocturnal Hemoglobinuria with Large Clones in Non-Hypoplastic Myelodysplastic Syndrome: Report of Two Cases.

Acta haematologica
2025

Case Report: Hepatocellular adenoma due to long-term oral stanozolol administration.

Frontiers in medicine
2025

A Case of Hepatosplenic Gamma Delta T Cell Lymphoma With Concomitant Bone Marrow Aplasia Following Azathioprine Therapy, Treatment Course and Review of the Literature.

Cancer reports (Hoboken, N.J.)
2025

Insights into Fanconi Anemia Based on Molecular and Clinical Characteristics: A Multicentre Study of 13 Patients.

Children (Basel, Switzerland)
2025

Case Report: Eltrombopag in mosaic and gene therapy-treated patients with Fanconi anemia.

Frontiers in pediatrics
2025

Hepatitis-associated Aplastic Anemia in Children: Unraveling Clinical Mysteries in a Single-center Case Series-More Questions Than Answers!

Journal of pediatric hematology/oncology
2025

Contemporary outcomes of octa-nonagenarians with newly diagnosed acute myeloid leukemia.

Cancer
2025

Oral Verruciform Xanthoma as a Manifestation of Chronic Graft-Versus-Host Disease in Fanconi Anemia: A Rare Case Report.

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
2025

[A new era in the treatment of aplastic anemia].

[Rinsho ketsueki] The Japanese journal of clinical hematology
2026

"I would love to talk to someone that actually understands": Psychosocial experiences of adults with Fanconi anemia.

Journal of health psychology
2025

Comprehensive review on Fanconi anemia: insights into DNA interstrand cross-links, repair pathways, and associated tumors.

Orphanet journal of rare diseases
2025

Alu-mediated FANCD2 exonic deletion contributes to Fanconi anaemia.

British journal of haematology
2025

Intrafamilial variability in Diamond-Blackfan anemia with a novel canonical splice-site variant in the RPL11 gene.

Laboratory medicine
2026

Successful Treatment of Aplastic Anemia Induced by Immune Checkpoint Inhibitors for Lung Cancer.

Internal medicine (Tokyo, Japan)
2025

Patient-Reported Meaningful Change in Symptoms and Impacts of Paroxysmal Nocturnal Hemoglobinuria (PNH) in Three Phase III Clinical Trials of Iptacopan.

The patient
2025

A decade of acquired aplastic anemia: insights from a Central South African Center.

The Pan African medical journal
2025

Haplo-hematopoietic stem cell transplantation and immunoradiotherapy for severe aplastic anemia complicated with nasopharyngeal carcinoma: A case report.

Open life sciences
2025

Eltrombopag for Bone Marrow Failure in Fanconi Anemia: Results From the Phase II Clinical Trial FANCREV.

European journal of haematology
2025

Case Report: Rare aplastic anemia in pediatric systemic lupus erythematosus: a case series and systematic literature review.

Frontiers in pediatrics
2025

Platelet glycosylation in myelodysplastic syndromes correlates with disease severity.

Blood advances
2025

Recessive FANCM cancer syndrome with high cancer risks, chemotherapy toxicity, chromosome fragility, and gonadal failure.

Genetics in medicine : official journal of the American College of Medical Genetics
2025

The incidence of paroxysmal nocturnal hemoglobinuria cell clones in the Nordic countries.

Annals of hematology
2025

Predictive factors of romiplostim response in patients with refractory aplastic anemia: data from two clinical trials.

Annals of hematology
2025

Association of TGF-β1 -509 C > T (rs1800469) polymorphism with bone marrow failure severity in Fanconi anemia subjects.

Molecular biology reports
2025

Germline and somatic genetic landscape of pediatric myelodysplastic syndromes.

Haematologica
2025

Up-front alternative donor HCT in severe aplastic anemia: gaps and opportunities to translate evidence into practice.

Blood advances
2024

[Recent advances in the treatment of paroxystic nocturnal hemoglobinuria].

La Revue du praticien
2025

Traditional Chinese medicine for intractable and rare diseases: Research progress and future strategies.

Intractable & rare diseases research
2025

Aplastic Anaemia Disease Burden From the Patient Perspective and Quality of Life in Zimbabwe by A. Maramba and J. Mupini.

Journal of blood medicine
2025

Oral iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria: final 48-week results from the open-label, randomised, phase 3 APPLY-PNH trial in anti-C5-treated patients and the open-label, single-arm, phase 3 APPOINT-PNH trial in patients previously untreated with complement inhibitors.

The Lancet. Haematology
2025

Life-Threatening Anemia and Thrombocytopenia in a Toddler with Influenza B: Case Report and Literature Review.

Children (Basel, Switzerland)
2025

Fanconi anemia patients with head and neck squamous cell carcinoma - a multi-center study.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
2025

THPO promoter mutation: a familial study on congenital amegakaryocytic thrombocytopenia.

Journal of genetics
2025

Eltrombopag in combination with immunosuppressive therapy in pediatric severe aplastic anemia: phase 2 ESCALATE trial.

Blood advances
2025

To enhance the detection of aplastic anemia in primary care settings: a population-based study in Italy.

Expert review of hematology
2025

Inborn errors of immunity underlie clonal T cell expansions in large granular lymphocyte leukemia.

The Journal of clinical investigation
2025

Successful dupilumab treatment in a patient with severe dermatitis following allogenic hematopoietic stem cell transplantation.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
2025

Rhino-orbito-cerebral mucormycosis after allogeneic hematopoietic stem cell transplantation for very severe aplastic anemia in a child: a case report.

Frontiers in pediatrics
2025

Current view on the etiopathogenesis of aplastic anemia.

The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology
2025

Anchored Indirect Treatment Comparison Finds Comparable Effects of Pegcetacoplan and Iptacopan in Paroxysmal Nocturnal Haemoglobinuria.

European journal of haematology
2025

Cyclosporine A Combined with Rituximab Successfully Treated Erythropoietin-Induced Pure Red Blood Cell Aplastic Anemia.

Case reports in nephrology and dialysis
2026

Mental health in the first generation of adults with Fanconi anemia.

Psychology, health & medicine
2025

From severe aplastic anemia with TERT variant to Wilson disease - associations or not.

Annals of hematology
2025

The Advancing Landscape of Paroxysmal Nocturnal Hemoglobinuria Treatment.

Turkish journal of haematology : official journal of Turkish Society of Haematology
2025

High-Power Laser Treatment for Oral Leukoplakia in Fanconi Anemia: A Case Series Report.

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
2025

Deficiency of the Fanconi anemia core complex protein FAAP100 results in severe Fanconi anemia.

The Journal of clinical investigation
2025

Diamond-Blackfan anaemia presents as pathological foetal CTG and severe neonatal anaemia.

BMJ case reports
2025

Pediatric Case of Calcineurin Inhibitor-Induced Pain Syndrome Diagnosed During Cyclosporine Therapy for Aplastic Anemia.

Cureus
2025

Telomere Length and Genetic Variations in Acquired Pediatric Aplastic Anemia: A Flow-FISH Study in Korean Patients.

Diagnostics (Basel, Switzerland)
2025

Loss of Ten1 in mice induces telomere shortening and models human dyskeratosis congenita.

Science advances
2025

Exploring the Fanconi Anemia Gene Expression and Regulation by MicroRNAs in Gilthead Seabream (Sparus aurata) at Different Gonadal Development Stages.

Marine biotechnology (New York, N.Y.)
2025

Acute hepatitis A-associated aplastic anemia in a pediatric: a case report from Syria.

Annals of medicine and surgery (2012)
2025

Clinical and genetic spectrum of SBDS and DNAJC21 gene variants in bone marrow failure cases: Atypical and cryptic presentations.

Blood cells, molecules & diseases
2025

Short-term recurrent coronary artery thrombosis with acute myocardial infarction in a patient with aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome: a case report.

Frontiers in cardiovascular medicine
2025

Eruptive Xanthoma With Pancytopenia: A Report of a Rare Case and Diagnostic Challenges.

Cureus
2025

A Rare Association of Celiac Disease and Aplastic Anemia.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
2025

Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement.

Blood
2025

Diagnosis and treatment of Diamond-Blackfan anemia and Pierre-Robin sequence caused by a novel mutation of RPS28 gene.

Hematology (Amsterdam, Netherlands)
2025

Impact of A Multidisciplinary Team Discussion for Genetic Lung Fibrosis.

Respirology (Carlton, Vic.)
2025

Infantile Pure Red Cell Aplasia Secondary to Deficiency of Adenosine Deaminase2 (DADA2) Syndrome-Time to Think Beyond Diamond Blackfan Anemia.

Pediatric blood & cancer
2025

Pathogenesis of paroxysmal nocturnal hemoglobinuria.

Blood
2025

Somatic mutations in Brazilian patients with paroxysmal nocturnal hemoglobinuria: a comprehensive analysis.

Frontiers in medicine
2025

RPS24 haploinsufficiency impairs erythropoiesis in the Diamond-Blackfan anemia zebrafish model via the STAT6-SATB1 pathway.

Biochemical and biophysical research communications
2025

Genetic Mutations Driving Aplastic Anemia: A Focus on Key Allelic Changes.

European journal of haematology
2025

Predictive Markers for Response to Immunosuppressive Therapy in Aplastic Anaemia.

Scandinavian journal of immunology
2025

Identification of 2 novel noncoding variants in patients with Diamond-Blackfan anemia syndrome by whole genome sequencing.

Blood advances
2025

[Observational Study on the Diagnostic Efficacy of Metagenomic Next-Generation Sequencing for Bloodstream Infections Secondary to Hematologic Diseases in Children].

Zhongguo shi yan xue ye xue za zhi
2025

Unveiling the role of RPS17 and SLC4A1 in diamond-Blackfan Anemia: A zebrafish-based study.

Blood cells, molecules & diseases
2025

Ethosuximide-associated Aplastic Anemia Likely Due to Drug-induced Lupus Erythematosus: A Case Report With Immunologic Insights.

Journal of pediatric hematology/oncology
2025

Aplastic Anemia as a Rare Manifestation of SAP Deficiency.

Pediatric blood & cancer
2025

Premature ageing of lung alveoli and bone marrow cells from Terc deficient mice with different telomere lengths.

Scientific reports
2025

Indications for Blood Transfusion and Exchange Transfusion in Sickle Cell Disease: A Single Center Experience.

Cureus
2025

Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry.

Blood advances
2025

Characterization of Ferroptosis-Related Genes in Aplastic Anaemia: An Integrated Analysis of Bulk and Single-Cell RNA Sequencing Data.

Acta haematologica
2024

Parvovirus B19-Induced Pancytopenia: A Case Report of Aplastic Crisis.

Cureus
2025

Gingival Debulking Surgery for a Child With Severe Aplastic Anemia: A Case Report.

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
2024

Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database.

Frontiers in pharmacology
2025

Case Report: A Novel Homozygous Variant in the SLX4 Gene Causes Fanconi Anemia.

Genetic testing and molecular biomarkers
2024

Current status and perspectives of hematopoietic cell transplantation in patients with paroxysmal nocturnal hemoglobinuria.

Frontiers in immunology
2025

Phase 1 study of quercetin, a natural antioxidant for children and young adults with Fanconi anemia.

Blood advances
2025

Rare Autoantibody Mimics Anti-C and Anti-e Specificity in Patient with Aplastic Anemia.

Clinical laboratory
2024

More Than a Haematoma: A Case of Aplastic Anemia.

Cureus
2025

A case of corneal opacity caused by atovaquone administration.

American journal of ophthalmology case reports
2024

Unusual outcome of treatment of thymoma with immunotherapy: case report.

Mediastinum (Hong Kong, China)
2025

Magnusiomyces capitatus, an Unusual Cause of Invasive Fungal Infections in Neutropenic Patients: Case Reports and Outbreak Investigation.

Mycopathologia
2025

Successful Antibiotic Treatment of Phlegmonous Gastritis Following Allogeneic Hematopoietic Stem Cell Transplantation.

Internal medicine (Tokyo, Japan)
2025

Severe aplastic anemia with acquired X chromosome clonality as a sole abnormality.

Annals of hematology
2025

Felbamate as a therapeutic alternative to drug-resistant genetic generalized epilepsy: a systematic review and meta-analysis.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2024

Diagnosis of Diamond-Blackfan anemia in adulthood: case series and review of the literature.

Orphanet journal of rare diseases
2024

A rare case report of severe aplastic anaemia caused by long-term use of zidovudine.

BMC infectious diseases
2024

Expert consensus on the management of pharmacodynamic breakthrough-hemolysis in treated paroxysmal nocturnal hemoglobinuria.

Hematology (Amsterdam, Netherlands)
2024

Aplastic Anemia: Demographic and Clinical Characteristics in Costa Rica.

Cureus
2026

Investigating the effects of the ARG258HIS mutation on RAD51C in inherited Fanconi Anemia and cancer disease.

Journal of biomolecular structure & dynamics
2025

Haematopoietic gene therapy of non-conditioned patients with Fanconi anaemia-A: results from open-label phase 1/2 (FANCOLEN-1) and long-term clinical trials.

Lancet (London, England)
2024

Feasibility and effectiveness of the prolonged use of eltrombopag in addition to immunosuppression in patients with acquired aplastic anemia: a single-center real-life experience.

Platelets
2025

Alu-Mediated Deletion of FANCA in Turkish Families With Fanconi Anemia: Evidence of a Founder Effect.

American journal of medical genetics. Part A
2024

Potential of ginsenoside Rg1 to treat aplastic anemia via mitogen activated protein kinase pathway in cyclophosphamide-induced myelosuppression mouse model.

World journal of stem cells
2025

Cord Blood Transplantation Using Myeloablative Conditioning for Pediatric Advanced Myelodysplastic Syndrome in AMeD Syndrome With a Novel ADH5 Variant.

Pediatric blood & cancer
2024

A multicentre, retrospective study of epidemiology and outcome of aplastic anaemia among adult population in Sabah and Sarawak from year 2006 to 2017.

The Medical journal of Malaysia
2024

Monitoring and Treatment of Paroxysmal Nocturnal Hemoglobinuria in Patients with Aplastic Anemia in Asia: An Expert Consensus.

International journal of molecular sciences
2025

Dental and Craniofacial Anomalies in Fanconi Anemia: A Systematic Review and Additional 46 Reports.

Oral diseases
2024

A novel nonsense RPS26 mutation in a patient with Diamond-Blackfan anemia: a case report.

Journal of medical case reports
2025

Aplastic anemia associated with osimertinib: Analysis of the FDA adverse event reporting system.

International journal of clinical pharmacology and therapeutics
2025

Prognostic significance of mutation type and chromosome fragility in Fanconi anemia.

American journal of hematology
2024

New Insights into the Fanconi Anemia Pathogenesis: A Crosstalk Between Inflammation and Oxidative Stress.

International journal of molecular sciences
2024

Contribution of p53-dependent and -independent mechanisms to upregulation of p21 in Fanconi anemia.

PLoS genetics
2024

A Rare THPO Gene Mutation in a Saudi Female Child: A Case Report and Literature Review.

Cureus
2025

Why hematopoietic stem cells fail in Fanconi anemia: Mechanisms and models.

BioEssays : news and reviews in molecular, cellular and developmental biology
2024

Severe acquired Factor VII deficiency complicating an aplastic anemia, successfully treated with corticosteroids.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
2024

A machine learning algorithm for the detection of paroxysmal nocturnal haemoglobinuria (PNH) in UK primary care electronic health records.

Orphanet journal of rare diseases
2024

Fatal Neutropenic Enterocolitis in a Young Female After the First Round of Eculizumab for Paroxysmal Nocturnal Hemoglobinuria.

Cureus
2024

FANCD2 genome binding is nonrandom and is enriched at large transcriptionally active neural genes prone to copy number variation.

Functional & integrative genomics
2024

Whole Exome Sequencing of Adult Indians with Apparently Acquired Aplastic Anaemia: Initial Experience at Tertiary Care Hospital.

Diseases (Basel, Switzerland)
2024

Very severe aplastic anemia in a child with pulmonary mucormycosis: a case report.

Frontiers in pediatrics
2024

Increased incidence of seronegative autoimmune hepatitis in children during SARS-CoV-2 pandemia period.

Frontiers in immunology
2025

Germline RTEL1 Variants in Telomere Biology Disorders.

American journal of medical genetics. Part A
2024

RPL26 variants: A rare cause of Diamond-Blackfan anemia syndrome with multiple congenital anomalies at the forefront.

Genetics in medicine : official journal of the American College of Medical Genetics
2024

[Acquired bone marrow aplasia in children and young adults under the age of 30: Experience of the Pediatric Hematology and Oncology Department of the 20 August Hospital, Casablanca].

Bulletin du cancer
2025

Clinical characteristics and management of paroxysmal nocturnal haemoglobinuria in Latin America: a narrative review.

Annals of hematology
2024

Accurate donor and recipient selection and a short time to transplant offer excellent outcomes in upfront hematopoietic stem cell transplantation from matched unrelated donors for pediatric severe aplastic anemia and refractory cytopenia of childhood. A study of the Spanish Pediatric Group for Hematopoietic Cell Transplantation and Cell Therapy (GETH-TC).

Bone marrow transplantation
2024

Small pituitary volume and central nervous system anomalies in Fanconi Anemia.

Frontiers in endocrinology
2024

Moving toward Individual Treatment Goals with Pegcetacoplan in Patients with PNH and Impaired Bone Marrow Function.

International journal of molecular sciences
2024

Clinical and Biological Perspectives on Noncanonical Esophageal Squamous Cell Carcinoma in Rare Subtypes.

The American journal of gastroenterology
2024

Fanconi Anaemia associated with café au lait spots: A rare case report.

JPMA. The Journal of the Pakistan Medical Association
2024

Encephalitis with Antibodies Against Glial Fibrillary Acidic Protein (GFAP) After Allogeneic Hematopoietic Stem Cell Transplantation: A Rare Case Report and Literature Review.

Journal of blood medicine
2024

Patient-reported outcomes and daily activity assessed with a digital wearable device in patients with paroxysmal nocturnal hemoglobinuria treated with ravulizumab: REVEAL, a prospective, observational study.

Health and quality of life outcomes
2024

Retrospective identification of the first cord blood-transplanted severe aplastic anemia in a STAT1-associated chronic mucocutaneous candidiasis family: case report, review of literature and pathophysiologic background.

Frontiers in immunology
2025

Methimazole-Induced Pancytopenia in a Patient with Graves' Disease: A Case Report and Literature Review.

Current drug safety
2024

Longitudinal clinical manifestations of Fanconi anemia: A systematized review.

Blood reviews
2024

Oral health-related quality of life in Fanconi anemia: a cross-sectional study.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
2024

A Rare Case of Iron Overload in Hereditary Spherocytosis: A Case Report.

Cureus
2024

Telomere length and clonal chromosomal alterations in peripheral blood of patients with severe aplastic anaemia.

British journal of haematology

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Anemia aplásica rara.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Anemia aplásica rara

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Towards evolutionary guided precision medicine of acute myeloid leukemia and Fanconi anemia associated bone marrow failure.
    Stem cells translational medicine· 2026· PMID 41814545mais citado
  2. Differential genetic analysis of ectrodactyly in a Fanconi anemia pedigree with FANCA mutations.
    MedScience· 2026· PMID 41733882mais citado
  3. Case Report: SLC52A2 variants cause Brown-Vialetto-Van Laere syndrome type 2, characterized by pure red cell aplastic anemia: clinical and genetic features of three Chinese children.
    Frontiers in pediatrics· 2026· PMID 41727768mais citado
  4. Pregnancy-induced aplastic anaemia with platelet refractoriness: clinical insights.
    BMJ case reports· 2026· PMID 41500703mais citado
  5. Acute severe cholestatic hepatitis and lymphopenia characterize pediatric hepatitis-associated aplastic anemia.
    Journal of pediatric gastroenterology and nutrition· 2026· PMID 41363020mais citado
  6. [The Effect of Haplo-Cord Mixed Chimerism on Lymphocyte Subsets in Aplastic Anemia after Haplo-Cord HSCT].
    Zhongguo Shi Yan Xue Ye Xue Za Zhi· 2026· PMID 41846351recente
  7. [The Efficacy of a New Ladder-Type Anti-Human Thymocyte Immunoglobulin in the Treatment of Severe Aplastic Anemia].
    Zhongguo Shi Yan Xue Ye Xue Za Zhi· 2026· PMID 41846350recente
  8. Cord blood transfusion added matched unrelated donor transplantation as a preferable choice for aplastic anaemia: a comparative study from a single centre.
    Ann Med· 2026· PMID 41840938recente
  9. Successful Treatment of Aplastic Anemia With Eltrombopag During Pregnancy: A Short Report.
    EJHaem· 2026· PMID 41821726recente
  10. The Role of IFN-γ-Mediated Immune Cell Crosstalk in the Pathogenesis of Aplastic Anemia.
    J Immunol Res· 2026· PMID 41811900recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:182040(Orphanet)
  2. OMIM OMIM:609135(OMIM)
  3. MONDO:0015909(MONDO)
  4. GARD:20234(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Artigo Wikipedia(Wikipedia)
  8. Q846316(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Anemia aplásica rara
Compêndio · Raras BR

Anemia aplásica rara

ORPHA:182040 · MONDO:0015909
Medicamentos
13 registrados
MedGen
UMLS
C0002874
Repurposing
11 candidatos
azacitidineDNA methyltransferase inhibitor
cyanocobalaminmethylmalonyl CoA mutase stimulant|vitamin B
decitabineglucocorticoid receptor agonist
+8 outros
EuropePMC
Wikidata
Wikipedia
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades